Development and synthesis of novel organocatalysts by McGeoch, Grant D.
Glasgow Theses Service 
http://theses.gla.ac.uk/ 
theses@gla.ac.uk 
 
 
 
 
McGeoch, Grant D. (2009) Development and synthesis of novel 
organocatalysts. PhD thesis. 
 
 
 
http://theses.gla.ac.uk/685/ 
 
 
 
 
 
Copyright and moral rights for this thesis are retained by the author 
 
A copy can be downloaded for personal non-commercial research or 
study, without prior permission or charge 
 
This thesis cannot be reproduced or quoted extensively from without first 
obtaining permission in writing from the Author 
 
The content must not be changed in any way or sold commercially in any 
format or medium without the formal permission of the Author 
 
When referring to this work, full bibliographic details including the 
author, title, awarding institution and date of the thesis must be given 
  
 
A thesis submitted in part fulfilment of the requirements of the degree 
of Doctor of Philosophy 
 
 
 
Development and Synthesis of Novel 
Organocatalysts 
 
 
 
Grant D. McGeoch 
 
University of Glasgow 
 
 
 
 
 
 
 
 
© Grant D. McGeoch 2008   P a g e  | ii 
 
   P a g e  | iii 
 
Abstract 
 
  The unfavourable use of metal-based catalysts in organic synthesis can be 
overcome by using small organic molecules; organocatalysts.  Herein we report the 
development and synthesis of a novel range of organocatalysts derived from amino 
acids incorporating imidazole, thiourea and phosphoramide moieties to confer the 
capability  to  act  as  bifunctional  organocatalysts.    Our  organocatalyst,  a 
phosphoramide derived from valine, showed initial success in the catalytic allylation 
of aldimine with allyltrichlorosilane, producing 40% ee. 
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  Oxazoline catalysts derived from 2-pyridines have been shown to be effective 
activators of trichlorosilane for the reduction of ketones and ketimines.  The reaction 
however suffered from chloride promoted ring opening of the catalyst.  By replacing 
the oxygen of the oxazoline moiety with sulphur we were able to successfully avoid 
this problem.  Further expansion of the substrate scope was achieved, heterocyclic 
imines were reduced in good enantioselectivity, up to 89% ee.  
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Preface 
 
  Environmentally friendly, selective and high yielding processes are integral 
to  the  development  and  synthesis  of  new  therapeutic  reagents  and  novel 
compounds.  This, coupled with the significance of chirality in nature and, more 
importantly,  the  human  body,  makes  the  efficient,  green,  generation  of 
enantiomerically enriched products a key goal in modern organic synthesis. 
  Generation of single enantiomers of chiral compounds can be achieved in a 
variety of ways: racemate resolution, chiral pool, chiral auxiliaries and asymmetric 
catalysis.  Racemate resolution is undesirable as the maximum yield is 50% and the 
unwanted enantiomer must be disposed of.  Molecules readily available from the 
chiral pool (amino acids, terpenes etc.) have limited variation in structure and so 
multi-step syntheses are required to reach the target molecule.  Chiral auxiliaries 
must be covalently bound to the substrate, this increases the number of steps in a 
synthesis and the auxiliary must also be recovered or disposed of.   
  Asymmetric catalysis is advantageous, as it uses achiral starting materials 
and  requires  only  a  catalytic  amount  of  the  chiral  molecule,  which  offers  the 
possibility of being recovered at the end of the synthesis.  Asymmetric catalysis is 
widely used in industry due to its advantages over other stoichiometric methods. 
  Most  commonly  in  industry,  transition  metal  complexes  are  used  as 
asymmetric  catalysts  because  of  their  high  reactivity  and  high  selectivity;  for 
example  ready-made  mixtures  of  some  catalytic  systems  are  commercially 
available,  eliminating  the  need  to  weigh  several  compounds.    Transition  metal 
catalysis has become so important that in 2001 the Nobel Prize for chemistry was 
awarded to Knowles, Noyori and Sharpless for their contributions to asymmetric 
catalysis.    However,  transition  metal  catalysis  is  not  free  from  problems.    The 
metals used are often expensive, toxic and can be difficult to recover from the 
reaction products.  In pharmaceutical products this can prove problematic due to 
the toxicity, cost of the metal and its recovery. These issues can be resolved by 
employing organocatalysis.
[1] P a g e  | 2 
 
  In  light  of  this,  the  field  of  organocatalysis  has  received  considerable 
attention in recent years.
[2,3]  Although organocatalysis has been known since the 
early part of the twentieth century at least
[4,5], the past decade has seen a vast 
advancement in the field.  There has been large growth in the number of papers 
published  in  this  area  and  the  number  of  new  organocatalytic  systems  being 
discovered.
[2,6,7]    Organocatalysts  are  small  organic  molecules.    They  offer  a 
favourable alternative to metals as they are less toxic, cheaper and can often be 
used under an aerobic atmosphere with wet solvents.  Small organic molecules also 
offer the possibility of being recovered and reused, unlike many transition metal 
catalysts.   
  Organocatalysts can act by coordination to the substrate to render it more 
reactive.  This is often the case when amines are used as organocatalysts and is 
typified by enamine activation shown by proline.
[8,9]  Organocatalysts can also act 
through weak non-covalent interactions: in this case the substrate or reagent is 
activated by coordination to the organocatalyst.  The activation of organosilicon 
reagents is one such example; this chapter will focus on the reactions of silicon 
reagents and the organocatalysts employed in these processes. 
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1 Introduction 
 
1.1 Lewis Basic Activation of Silicon 
 
  Addition of nucleophilic reagents to carbonyl compounds is an area with 
great importance in organic synthesis.  Reactive nucleophiles such as LiAlH4 and 
Grignard reagents efficiently add to carbonyl compounds, however less reactive 
nucleophiles such as allyltrichlorosilane and trichlorosilane do not react so readily 
and additional activation is required.  This can be achieved by either adding a Lewis 
acid to trialkylsilanes or a Lewis base in the case of trichlorosilanes (Scheme 1.1). 
 
O
H R
OH
R
MgBr
SiMe3
SiCl3
+ LA
+ LB
*
 
Scheme 1.1: Activation of silanes. 
 
  Activation can occur through either Lewis acid coordination to the carbonyl 
oxygen  or  through  Lewis  basic  activation  of  the  nucleophilic  silane  compound.  
Typically in organocatalysis activation of silanes  by Lewis bases is the preferred 
method.
[10]  As  organosilicon  reagents  are  generally  unreactive,  only  the 
coordinated silicon species will react.  If the activator employed can dissociate from 
the silicon intermediate at a sufficient rate, it can act as a catalyst rather than a 
stoichiometric reagent.  The use of a chiral Lewis basic catalyst would naturally 
allow for the preferential formation of a single enantiomer.  
 P a g e  | 4 
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Figure 1.1: Expanding coordination of organosilicon reagents 
 
  Coordination of a Lewis base to an organosilicon reagent, 1, can expand the 
coordination sphere of silicon resulting in a pentacoordinate, 2, or hexacoordinate, 
3, species.
[11,12]  This results in increased positive charge on silicon and increases the 
negative charge on the ligands (Figure 1.1).
[13,14]  If the increased negative charge 
lies on a ligand which may act as a nucleophile then the hypervalent species can be 
considered as activated towards nucleophilic attack on an electrophile.  In the case 
of hexacoordinate silicon, 3, it is possible for a cationic species to be generated by 
ionisation of an electron-withdrawing ligand, such as a halide.  This results in a 
significant increase in Lewis acidity at silicon and can hence facilitate the activation 
of an electrophile, such as a carbonyl group, by coordinating to a non-bonding lone-
pair of oxygen.
[15]  Organocatalytic protocols based on silane reagents have taken 
advantage  of  the  tendency  of  Lewis  bases  to  activate  silane  reagents  as 
nucleophiles and enhance the Lewis acidic character of silicon.
[16] 
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1.2 Allylation Reactions at C=O 
 
  The addition of allylsilanes to aldehydes is an important carbon-carbon bond 
forming  reaction  that has  come  under  much  recent  scrutiny.
[2,17,18]    Part  of the 
reason for the interest in this reaction has been the ability to generate homoallylic 
alcohols with high enantio- and diastereoselectivity and the synthetic versatility of 
the  end  product.    Although  the  reaction  is  typically  carried  out  by  Lewis-acidic 
(metallic)  activation  of  the  carbonyl  component  or  by  employing  reactive 
organometallic  allyl  reagents,  the  development  of  Lewis  basic  activation  of 
allylsilanes  has  allowed  the  use  of  organic  molecules  as  promoters 
(organocatalysts). 
  Lewis base promoted allylation of aldehydes with allylsilanes was pioneered 
by  Kobayashi  using  dimethylformamide  as  a  stoichiometric  activator  of 
allyltrichlorosilane, 4.
[19,20]  Interestingly, when crotyltrichlorosilanes, 5, were used, 
the reaction proceeded stereospecifically suggesting the reaction operates via a 
closed cyclic transition state, 6 (Scheme 1.2).   Since this initial discovery, a range of 
further  Lewis  basic  substances  that  facilitate  the  allylation  reaction  have  been 
identified.  Typical Lewis basic activators include DMSO
[19-22] and HMPA
[22,23] as well 
as compounds with formamide
[24,25] and urea
[26] structural motifs. 
 
O
Si H
R2
R1
Cl O
Cl
Cl
N
H
Me Me
R2
R1 SiCl3
R
O
R H
OH
R
R2 R1
DMF
+
4: R1=H, R2=H
(trans)-5: R1=Me, R2=H
(cis)-5: R1=H, R2=Me
6
 
Scheme 1.2: Kobayashi closed TS 
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1.2.1 Phosphoramide Organocatalysed Allylations 
 
  The asymmetric Lewis base promoted allylation of aldehydes was pioneered 
by  Denmark  who  showed  that  chiral  phosphoramides  were  able  to  successfully 
produce  enantioenriched  homoallylic  alcohols,
[22]  although  the  phosphoramide 
catalyst 7 exhibited only modest enantioselectivity.  It was shown that the addition 
of trans and cis 5 resulted in generation of the anti or syn products respectively, 9, 
with high diastereoselectivity (Scheme 1.3).  The transfer of stereochemistry from 
double  bond  to  product  in  the  crotylation  reaction  strongly  suggests  that  the 
reaction proceeds via a closed cyclic transition state, much like that proposed by 
Kobayashi. 
 
H
O OH
R2 R1
SiCl3
R2
R1
N
P
N
Me
Me
O
N
CH2Cl2, -78 oC
+
4: R1=H, R2=H
(trans)-5: R1=Me, R2=H
(cis)-5: R1=H, R2=Me 7
silane cat loading (%) yield (%) anti/syn ee (%)
4
(trans)-5
(cis)-5
100
100
100
80
68
72
N.A.
98/2
2/98
60
64
60
6 8: R1=H, R2=H
(anti)-9: R1=Me, R2=H
(syn)-9: R1=H, R2=Me
 
Scheme 1.3: Phosphoramide catalysed allylation of benzaldehyde – Denmark 
 
  To further probe the reaction mechanism and dependence of selectivity on 
catalyst  loading,  a  kinetic  study  was  carried  out  by  Denmark.
[27]    A  non-linear 
relationship  between  the  enantiopurity  of  catalyst  7  and  product  8  was  found, 
suggesting that two molecules of catalyst are involved in the transition state.  It was 
also proposed that a second, less selective one-catalyst pathway may operate at 
low  phosphoramide  levels.    In  order  to  reduce  the  effects  of  the  second,  less 
selective pathway, Denmark designed bisphosphoramide catalysts (Chart 1.1).
[27,28]  P a g e  | 7 
 
Variation of the length of carbon chain linking the phosphoramide units identified a 
five-methylene tether as the optimum, 10b.  Increased selectivity was observed 
with the use of organocatalysts 11a-c, derived from (R,R)-2,2’-bispyrrolidine.  Again, 
the  optimum  tether  length  was  determined  as  five  methylene  units.    Bis-
phosphoramide  11b  catalysed  allylation  of  benzaldehyde  6  (loading  of  5  mol%) 
furnishing  the  allylic  alcohol  in  85%  yield  and  87%  ee.      Catalyst  11b  was  also 
successful in the allylation of a range of aromatic, heteroaromatic and unsaturated 
aldehydes.
[28] 
 
N
P
N
Me
Me
O
N
P
N
Me
Me
O
n N
P
N O
N
P
N O
n H
H H
H
10a: n=4
10b: n=5
10c: n=6
11a: n=4
11b: n=5
11c: n=6  
Chart 1.1: Bis-phosphoramide organocatalysts. 
 
  In order to further understand the reaction mechanism, Denmark carried 
out a number of studies involving bis-phosphoramide catalysts 10b and 11b.
[29]  In 
these studies, complexes of phosphoramides with SnCl4 were synthesised and their 
properties were studied both in solution and in solid state.  Complexes with Sn 
exhibit similar bonding to those of Si but are also more stable making them easier 
to study.  The similarity in bonding between Si and Sn complexes allows results 
based  on  Sn  to  be  extrapolated  to  the  corresponding  Si  complexes.    Based  on 
crystallographic data and 
31P and 
119Sn NMR studies, Denmark proposed that trans-
coordination  of  the  silane  to  the  Lewis  basic  organocatalyst  enhances  the 
nucleophilicity  of  the  allyl  group.    In  addition,  the  aldehyde  should  preferably 
coordinate trans to the electron-withdrawing chloride group to enhance its anionic 
character.  Coordination of both Lewis basic catalyst and aldehyde to silicon in this 
fashion generates a chiral pocket, 12, in which enantioselective allylation can occur 
(Figure 1.2).   
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Si
LB
Cl
LB
Cl
Cl
O R
R1
R2 12
 
Figure 1.2: Proposed method of allylation promoted by Lewis basic organocatalysts. 
 
1.2.2 N-Oxide Organocatalysed Allylations 
 
N N
O O
13 Nakajima
N N
Ph O O Ph
OH HO
14 Hayashi
N
O
R R
15 R = H; PINDOX
16 R = Me; Me2PINDOX
N N
O
17 iso-PINDOX
N
O O
O
O
18 METHOX
N
O O
19 QUINOX
 
Chart 1.2: N-oxide based organocatalysts for allylation reactions 
 
  Another  successful  class  of  organocatalysts  for  the  Lewis-base  promoted 
allylation with allyltrichlorosilanes are N-oxides (Chart 1.2).  The use of N-oxides 
was  pioneered  by  Nakajima,  who  demonstrated  that  chiral  N,N’-bisoxide  13 
allowed successful transformation in high yield and selectivity (71 – 92% ee) at -78 
oC with a catalyst loading of only 10 mol% (Table 1.1, entries 1-4).
[30]  Similar to the 
phosphoramide catalysed allylation reactions, a six-membered transition state was P a g e  | 9 
 
proposed due to the high diastereoselectivitiy observed upon the addition of trans 
and cis crotylsilanes (Figure 1.2). 
  Further to Nakajima’s work, a more active N,N’-bisoxide 14 was developed 
by Hayashi.
[31]  High yields are observed with as little as 0.1 mol% catalyst loading; 
however enantioselectivity was highly dependent on the electronic nature of the 
substrate aldehyde (Table 1.1, entries 5, 6).  Electron-deficient aldehydes produced 
homoallylic alcohols with lower enantioselectivity than that of their electron-rich 
counterparts.    Hayashi suggested  that  the difference between electron-rich  and 
electron-poor aldehydes could be attributed to π-stacking between the aldehyde 
and catalyst in the transition state. 
 
Ar H
O
Ar
OH
R2 R1
SiCl3
R2
R1
+
4: R1=H, R2=H
(trans)-5: R1=Me, R2=H
(cis)-5: R1=H, R2=Me
silane catalyst yield (%) anti/syn ee (%)
4
(trans)-5
(cis)-5
Ar
4
Ph 13 85 NA
4-MeOC6H4 91
Ph
Ph 13
68 97/3
64 1/99
NA
4
4
Ph
4-MeOC6H4
14 95 NA 84 (S)
88 (R)
92 (R)
86 (R)
84 (R)
14 96 NA 94 (S)
13
13
*
entry
1
2
3
4
5
6
Table 1.1: Allylation with bis-N-oxides 13 and 14. 
 
  Malkov and Kocovsky reported the use of a series of catalysts derived from 
terpenes; bypyridine N-monoxides 15 – 17.
[32,33]  N-oxide 15, PINDOX, emerged as 
an efficient catalyst for the allylation of aromatic and heteroaromatic aldehydes 
(Table 1.2, entries 1 - 5).  Further studies, however, revealed that Me2-PINDOX 16 
was much more efficient than its analogues PINDOX, 15, and iso-PINDOX, 17.  It was 
proposed  that  the  restriction  to  axial  rotation  imposed  by  3,3’-methyl  groups 
created a favourable chiral environment upon coordination to silicon.  Asymmetric P a g e  | 10 
 
induction is controlled by the configuration of the 2,2’-bipyridyl bond as shown by 
using both the (+) and (-) atropisomers of Me2-PINDOX, 16.  Thus, when the (+) 
atropisomer (10 mol%) was used, the homoallylic alcohol (S)-8 was isolated in 72% 
yield and 98% ee (Table 1.2, entry 6); while (-)-16 results in the formation of the (R)-
8 in 82% ee and 67% yield (Table 1.2, entry 7).  To account for the observed results, 
a  bidentate  coordination  of  silicon  through  both  O  and  N  resulting  in  a 
hexacoordinate silicon species was proposed. 
 
entry catalyst Ar yield (%) ee (%)
1 Ph 78 90 (S)
2 4-MeOC6H4 68 87 (S)
3 4-NO2C6H4 58 65 (S)
4 52 83 (S)
5 2-furyl 63 85 (S)
6
15
15
15
15
15
(+)-16 Ph 72 98 (S)
7 (-)-16 Ph 67 82 (R)
8 17 Ph 15 97 (S)
9 17 4-MeOC6H4 41 91 (S)
10 17 25 96 (S)
PhCH=CH2
PhCH=CH2  
Table 1.2: Allylation of aldehydes with PINDOX and its derivatives. 
 
  It was discovered that METHOX, 18, lacking the second pyridine ring was 
much more active and achieved the same levels of enantioselectivity as PINDOX 
analogues,  15  -  17.
[34,35]    In  light  of  this  Malkov  and  Kocovsky  proposed  that 
aromatic interactions between the catalyst and substrate may play a crucial role in 
determining  the  configuration  of  the  transition  state,  rather  than  a  second 
coordination point for Si.  In addition it was found that METHOX, 18, remained 
highly active even at low loadings (1 mol%) and is tolerant of aldehyde electronics 
(Table 1.3, entries 1-5). 
  While METHOX exhibited good selectivity regardless of aldehyde electronics, 
related N-oxide catalyst, 19, QUINOX displays high dependence on the electronics 
of the substrate aldehyde.
[36]  Employing QUINOX, 19, it was found that the reaction 
of  electron-poor  aldehydes  proceeded  with  higher  rate  and  selectivity  than  the P a g e  | 11 
 
equivalent  electron-rich  aldehydes  (Table  1.3,  entries  6–9).    More  recent 
investigations  involving  computational  and  kinetic  studies  by  Malkov  and  co-
workers  have  indicated  that  the  reaction  is  likely  to  proceed  via  an  associative 
reaction mechanism involving one molecule of organocatalyst that generates an 
octahedral silicon complex, 20 (Figure 1.3).
[37]   
 
entrya catalyst Ar yield (%) ee (%)
1 18 Ph 95
2 18 Ph
loading (%)
5
1 68
3 18 4-CF3-C6H4 5 86
4 18 4-MeO-C6H4 5 95
5 18 2-MeO-C6H4 5 95
6 19 Ph 5 60
7 19 4-MeO-C6H4 5 70
8b 19 4-NO2-C6H4 5 73
9 19 4-CF3-C6H4 5 85
[a] All reactions carried out at -40 oC. [b] Reaction complete after 12h
87 (R)
12 (R)
89 (R)
96 (R)
solvent
CH2Cl2
CH2Cl2
CH2Cl2
CH2Cl2
MeCN
MeCN
MeCN
MeCN
MeCN
96 (S)
95 (S)
93 (S)
96 (S)
89 (S)
 
Table 1.3: Allylation of aldehydes with 18 and 19. 
 
 
O
Si H
Ph
Cl Cl
O
Cl
N
MeO
20
 
Figure 1.3:  Proposed TS for allylation of aldehydes with QUINOX 19. 
 
  Crotylation of aldehydes catalysed by PINDOX and its derivatives, 15 - 17, 
resulted in the highly diastereoselective formation of homo-allylic alcohols 9.  The 
transfer of stereochemistry from double bond to alcohol was consistent with the 
presence of a closed cyclic transition state, i.e. the trans alkene produces the anti 
product  and  cis  gives  the  syn  products.    METHOX  reacts  well  with  trans-5, 
generating anti-9 with very high diastereoselectivity (>99:1) and high ee (95%).  The 
reaction with cis-5 however is slow and not as diastereoselective (6:1). P a g e  | 12 
 
  Crotylation  with  QUINOX,  19,  as  the  organocatalyst  has  been  shown  to 
exhibit high diastereoselective control.
[36,37]  Reaction with trans and cis-5 formed 
the  corresponding  allylic  alcohols  with  high  diastereoselectivity,  95:5  and  1:99 
respectively (Table 1.4).  It was again observed that electron-rich aldehydes did not 
react  as  well  as  their  electron-poor  counterparts.  The  results  indicate  that 
crotylation  with  QUINOX,  19,  proceeds  via  a  closed  chair-like  transition  state, 
similar  to  that  proposed  by  Denmark  (Figure  1.4).    Computational  studies  also 
suggested that aromatic interactions between catalyst and substrate may play a 
contributory role in the enantiodifferentiation process. 
 
 
R Silane Yield anti:syn
CF3 trans 75 96:4
H trans 65 95:5
CF3 cis 85 1:99
H cis 78 1:99
MeO trans 40 83:17
MeO cis 50 4:96
O
R
SiCl3
R2
R1
R
OH
R2 R1 CH2Cl2, -40 oC
(trans)-5: R1=Me, R2=H
(cis)-5: R1=H, R2=Me
+
(S)-QUINOX
(anti)-9: R1=Me, R2=H
(syn)-9: R1=H, R2=Me
 
Table 1.4: Crotylation of aldehydes with QUINOX 
 
SiCln O
LB*
Closed TS
high diastereoselectivity 
Figure 1.4: Allylation transition state, LB* = chiral Lewis Base (organocatalyst) P a g e  | 13 
 
  The application of tri-N-oxides as Lewis basic activators for this reaction has 
also been reported by Kwong.
[38]  Terpene derived pyridine-N-oxides 21 – 22 were 
shown to be effective with loadings of 10 mol% (Chart 1.3, Table 1.5).  Enantiomeric 
excess  of  up  to  86%  ee  was  reported  however  the  selectivity  proved  to  be 
dependent on the electronics of the aldehyde; again; electron-poor aldehydes gave 
the highest selectivity. 
 
N
N N O
O O
N
N N O
O O
R R
21 22a R = n-Bu
22b R = Bn  
Chart 1.3: Terpene derived N-oxide organocatalysts 
 
O
R H
SiCl3
R
OH
Entry Catalyst R Yield (%) ee (%)
1 21 Ph 85 34 (R)
2 22a Ph 87 67 (R)
3 22b Ph 89 74 (R)
4 22b 4-MeO-C6H4 94 65 (S)
5 22b 4-CF3-C6H4 91 86 (R)
+
i-PrNEt2, CH2Cl2
O oC, 3 h
Catalyst 10 mol%
*
 
Table 1.5: Allylation catalysed by tri-N-oxides 21 – 22. 
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1.2.3 Formamide Organocatalysed Allylations 
 
  Chiral  formamides  have  also  been  employed  as  organocatalysts  for  the 
allylation of aldehydes based upon the work of Kobayashi.
[19]  Chiral DMF analogues 
were developed by Iseki and employed in the allylation reaction.
[24,25]   Formamide 
23 was found to be an activator for the reaction however long reaction times at low 
temperature (7 days at -78 
oC) were required to produce the allylic alcohol 24 in 
81%  yield  and  68%  ee  (Scheme  1.4).    It  was  found  that  the  addition  of  1.0 
equivalents of HMPA was beneficial to the reaction.  The product was formed in 
80% yield and 98% ee under optimum conditions, 1.0 eq HMPA as an additive, -78 
oC, 14 days.  Although 23 operates as a highly selective catalyst, the reaction rate is 
too sluggish to be considered synthetically useful.  It is worth noting, however, that 
23 exhibits high selectivity for aliphatic aldehydes (≥ 98% ee) but not with aromatic 
aldehydes. 
 
Me
N
Me
O H
23
O
H SiCl3
OH
+
CH2Cl2, HMPA
-78 oC, 14 days
(S,S)-23
(R)-24 80%, 98% ee
 
Scheme 1.4: Allylation reaction promoted by (S,S)-23. 
 
  More recently, Kobayashi described the use of a polymer supported 
formamide, 25, which can act as a recyclable promoter for the allylation of 
aldehydes with silanes (Scheme 1.5).
[39]  Allylic alcohol 26 was formed in 91% yield 
using one equivalent of polymer supported catalyst 25.  It was also found that 25 
maintained its activity through several uses. 
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O
H SiCl3
OH
+
N
Me
H
O
25
Scheme 1.5: Allylation catalysed by polymer supported formamide. 
 
1.2.4 Pyridine-oxazoline Organocatalysed Allylations 
 
  The  use  of  pyridine-oxazoline  derivatives  as  activators  for  crotylation  of 
aromatic aldehydes was reported by Barrett.
[40]  Organic activator 27 derived from 
leucinol  showed  the  best  results  for  this  transformation,  giving  excellent 
diastereoselectivity, >99% and moderate-to-good enantioselectivity, 36 – 74% ee 
(Scheme 1.6).  Formation of the anti-allylic alcohol only, indicates the involvement 
of a hyper-valent silicon species in a closed transition state. 
 
O
R H
SiCl3 R
OH
Me
+
27 110 mol%
CH2Cl2
-78 oC, 4 h
N
N
O
27
Entry R Yield (%) ee (%)
1 Ph 72 74
2 4-MeO-C6H4 79 46
3 4-F-C6H4 61 74
4 4-O2N-C6H4 66 36
 
Scheme 1.6: Crotylation of aldehydes catalysed by pyridine-oxazolines. 
 
   P a g e  | 16 
 
1.3 Reduction of Ketones With Silanes 
 
  Silanes  are  widely  accepted  as  efficient  reagents  for  the  reduction  of 
carbonyl functionality.  In the case of alkyl silanes, transition metal catalysts are 
required to activate the reagent
[41]; in the case of more Lewis acidic trichloro- and 
trialkoxysilanes, a metal-free variation can be attained by employing an organic 
activator (Scheme 1.7). 
     
O
R2 R1
X3SiH +
OH
R2 R1
Activator
*  
Scheme 1.7: Reduction of ketones with silanes 
 
1.3.1 Anion Promoted Reduction 
 
  Trialkoxysilanes were reported as reducing agents for carbonyl compounds 
by  Corriu.
[42,43]    Although  generally  unreactive  towards  carbonyl  functionality, 
triethoxysilane turned into a reactive hypervalent silicon species upon coordination 
of  fluoride  anions.    A  range  of  carbonyl  compounds  were  reduced  by  silanes 
catalysed by alkali metal fluorides. 
  More recently, Lawrence has reported the use of chiral quinidine fluoride 
salts  as  phase-transfer  catalysts  for  an  asymmetric  variant  of  this  reaction.
[44]  
Activation of trimethoxysilane is again achieved by forming a hypervalent silicon 
species with fluoride anions.  The use of chiral cinchona derived catalyst 28 led to 
the formation of sec-alcohols in up to 78% ee (Scheme 1.8).  It was also found that 
aromatic sec-alcohols were formed with higher levels of enantiodiscrimination than 
their aliphatic counterparts. 
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N
Ph
N
OMe
H HO
O OH
29 (S)-30, 99%, 78% ee
28 10 mol%
(Me3SiO)3SiH
THF
28
 
Scheme 1.8: Reduction of ketones with cinchona derivative 28 
 
  Alkoxides also turned into effective activators of silicon for the reduction of 
ketones  to  alcohols  with  silanes  as  shown  by  Hosomi  (Chart  1.4).
[45]    Lithium 
alkoxide 31 generated a hypervalent silicon species which converted a range of 
ketones to the corresponding alcohols in good yield.  Hosomi then developed chiral 
alkoxides  as  activators  of  silicon,  resulting  in  an  asymmetric  transformation.
[46]  
Alkoxide 32 successfully reduced acetophenone, 29, in 78% yield and 44% ee with a 
loading of 40 mol%.   
  Additionally, lithium salts of L-Histidine and BINOL have been developed as 
activators of trialkoxysilanes by Brook
[47,48] and Kagan
[49] respectively.  The lithium 
salt of L-Histidine, 33, formed (S)-phenylethanol, 30, in 70% yield and only 26% ee; 
the monolithium salt of BINOL, 34, formed (S)-phenylethanol, 30, in 92% yield and 
70% ee;  34 was also shown to be highly effective for a range of ketones forming 
the  sec-alcohol  products  in  good  selectivity  (up  to  93%  ee).    In  both  cases  the 
addition of TMEDA was found to be beneficial to the activity of the catalytic system, 
presumably as it prevents the organolithio compounds from aggregating. 
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LiO
LiO
LiO
LiO
OBn
OBn
LiO O
NH2
N
N
Li
OH
OH
31 32 33 34  
Chart 1.4: Lithium alkoxide activators 
 
1.3.2 Formamide Promoted Reduction 
 
  Kobayashi described the reduction of ketones to sec-alcohols with the use of 
a dimethylformamide-trichlorosilane complex.
[50]  The hypervalent silicon complex 
thus generated was shown to be an effective reducing agent for ketones, aldehydes 
and imines.  Trichlorosilane proved to be a more desirable reducing agent than 
trialkoxysilanes as it is less toxic, cheap and easy to handle.  Perhaps unsurprisingly, 
this  led  to  the  development  of  chiral  formamide  derivatives  as  activators  of 
trichlorosilane for the reduction of the carbonyl functionality. 
 
N
O H
N
O H
N
O H
H
N Ph
H
N
O O
N HO2C
Et
Et
Et O
35 36 37 38
Chart 1.5: Formamide activators of Cl3SiH 
 
  Matsumura  showed  that  N-formylpyrrolidine  derivatives  were  able  to 
effectively  activate  trichlorosilane  towards  reduction  in  only  catalytic  quantities 
(Chart 1.5).
[51]  The initial non-enantioselective reduction was carried out with 10 
mol% of formamide 35, resulting in formation of phenylethanol in 92% yield.  By 
employing chiral formamide 36 derived from proline some enantiodiscrimination 
was  observed.    Enantioselectivity  was  increased  when  formamide  37  was 
employed, giving the product in 43% ee.  Matsumura proposed steric repulsion P a g e  | 19 
 
between  the  aryl  groups  of  the  catalyst  and  ketone  as  a  rationale  for 
enantioinduction (Figure 1.5). 
 
N
O
H
HN
O
Si
H
Cl Cl
O
Me
Cl N
O
H
HN
O
Si
H
Cl Cl
O
Cl
favoured disfavoured  
Figure 1.5: Matsumura’s proposed transition state. 
 
  More recently, Matsumura reported the related formamide 38 (Chart 1.5) 
as an efficient activator of silanes towards reduction of ketones.
[52]  Formamide 38 
reduced  aromatic  ketones  containing  both  electron-donating  and  electron-
withdrawing  substituents  in  high  selectivity,  up  to  97%  ee  (Table  1.6).    Acetyl 
ferrocene was also successfully reduced by 38 at -60 
oC in 97% yield and 99.7% ee.  
It was found that the carboxyl group and 2,4,6-triethylphenyl group at the α and α’ 
positions  were  required  for  high  selectivity  and  reactivity.    This  may  suggest 
hydrogen bonding interactions between the catalyst and either ketone or silane.  
Aromatic interactions between catalyst and substrate may also be suggested as a 
rationale for selectivity.   
 
Entry R Yield (%) ee (%)
1 Ph 90 95 (R)
2 4-NO2-C6H4 93 97 (R)
3 93 97 (R)
4 91 94 (R)
O
R Me
OH
R Me HSiCl3, CHCl3
rt
38 10 mol%
4-Cl-C6H4
4-F-C6H4
 
Table 1.6: Reduction of ketones with formamide 38. P a g e  | 20 
 
 
  Pipecolinic  derived  formamides,  39  –  43  (Chart  1.6),  were  found  to  be 
effective for the reduction of ketones with trichlorosilane by Sun and co-workers.
[53]  
Formamide  derivative  43  was  found  to  be  the  most  efficient  promoter  of  the 
reduction  reaction;  aromatic  ketones  were  reduced  in  high  yield  and 
enantioselectivity (Table 1.7, entries 1 – 3).  Interestingly, aliphatic ketones were 
effortlessly reduced in moderate to high selectivity (Table 1.7, entries 4 and 5).   
 
N
O H
H
N Ph
Ph O
Ac
O
N
O H
H
N Ph
Ph O
R
O
39 40 R = Ac
41 R = CHO
42 R = Et
43 R = Me  
Chart 1.6: Pipecolinic derived formamide organocatalysts. 
 
 
Entry R Yield (%) ee (%)
1 4-CF3-C6H4 92 92 (R)
2 4-NO2-C6H4 92 91 (R)
3 Ph 94 81 (R)
4 c-C6H11 90 88 (R)
5 i-Pr 81 53 (R)
O
R Me
OH
R Me HSiCl3, toluene
-20 oC
43 10 mol%
 
Table 1.7: Reduction of ketones with formamide 43. 
 
  The  methoxy  substituent  at  the  2’  position  was  found  to  be  crucial  to 
enantiodifferentiation  as  replacement  of  this  group  results  in  lower  selectivity.  
Furthermore it was found that reversal of the stereochemistry at C-2’ or removal of P a g e  | 21 
 
the alkoxy group had a detrimental effect on both selectivity and reactivity.  Based 
on  their  observed  results,  Sun  et  al  proposed  a  transition  state  based  on 
tricoordinate  activation  of  silane  by  the  organocatalyst  to  generate  a 
heptacoordinate silicon species, 44, as the active reducing agent (Figure 1.6). 
 
Si
Cl
O
Cl H
O Cl H
N
H
N
O Me
Ph Ph
O R
44
 
Figure 1.6: Sun proposed transition state for reduction of ketones. 
 
1.3.3 Oxazoline Promoted Reduction 
 
 
N
N
O N
N
O N
N
O
Ph Ph
Ph
45 46 47  
Chart 1.7: Pyridine oxazoline activators of silanes 
 
  More  recently  Malkov  and  Kocovsky  described  the  use  of  pyridine 
oxazolines  as  highly  effective  organocatalysts  for  the  reduction  of  ketones  with 
trichlorosilane (Chart 1.7).
[54]  When phenylglycine derived pyridine oxazoline 45 
was effectively employed for the hydrosilylation of acetophenone, 29, the resulting 
alcohol, 30, was obtained in low yield and moderate enantioselectivity (Table 1.8, 
entry 1).  In contrast, the isomeric pyridine oxazoline 46, obtained from mandelic 
acid,  reduced acetophenone,  29,  in 85%  yield and 78%  ee  (Table  1.8,  entry  2).  
Steric interactions between the chiral aryl group and the silane ligands, resulting in 
poor coordination of the silane to 45, were proposed to account for the difference 
in  selectivity  between  45  and  46.    A  range  of  ketones  were  examined  in  the P a g e  | 22 
 
reduction reaction catalysed by 46, high enantioselectivity was observed only in 
aromatic ketones (>80% ee), while aliphatic ketones performed rather poorly.   
  In  order  to  increase  activity  and  selectivity,  catalyst  47  derived  from  1-
isoquinoline and mandelic acid was developed.  Catalyst 47 was shown to be much 
more  active  over  a  range  of  substrates  and  allowed  the  catalyst  loading  to  be 
dropped to  10  mol%.    Aromatic  ketones  were  reduced  in  good  yield  with  high 
enantioselectivity, >94% (Table 1.8, entries 3 – 7).  Malkov and Kocovsky proposed 
a transition state accounting for the high selectivity in which the oxazoline catalyst 
coordinates to trichlorosilane to form a hypervalent silicon species.  The ketone, 
coordinated to a second molecule of trichlorosilane, then approaches from the less 
hindered face; it was also suggested that aromatic interactions between ketone and 
catalyst may play a role in stabilising the transition state, 48 (Figure 1.7). 
 
O
R2 R1 CHCl3, -20 oC, 24 h
Organocatalyst
+ Cl3SiH
OH
R2 R1
Entry Catalyst (mol%) R1, R2 Yield (%) ee (%)
1
2
3
4
5
6
7
45 (20)
46 (20)
47 (10)
47 (10)
47 (10)
47 (10)
47 (10)
Ph, Me
Ph, Me
Ph, Me
2-naphth, Me
Ph, Et
2-F-C6H4, Me
2-MeO-C6H4
29 66
85 78
85 84
55 86
50 87
35 70
93 94
 
Table 1.8: Organocatalytic reduction of ketones with oxazoline derivatives 
 
N N
O Ph
H Si
Cl
Cl Cl
H
Me
O SiHCl3
*
48  
Figure 1.7: Proposed transition state for catalyst 46. 
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1.4 Reduction of Imines with Silanes 
 
1.4.1 Anion Promoted Reduction 
 
  As an outcome to the activation of trialkoxysilanes for the hydrosilylation of 
ketones,  Hosomi  reported  the  use  of  lithium  methoxide  as  a  catalyst  for  the 
reduction of N-tosyl imines with trimethoxysilane.
[55]   
  Attempts to render the reaction enantioselective by using lithium salts of 
various  amino  alcohols  were  unsuccessful  however.
[56]    An  improvement  in 
selectivity was observed using the dilithium salt of BINOL, 34.  The reduction of 49 
to 50 was carried out successfully in 65% enantioselectivity. 
 
N
Me Ph (MeO)3SiH
Catalyst HN
Me Ph
Catalyst = LiOMe: 63%
Catalyst = BINOL-Li2: 65% ee
*
49 50
Ts Ts
 
Scheme 1.9: Reduction of N-tosyl imines 
 
1.4.2 Formamide Promoted Reduction 
 
  Analogous to the reduction of ketones, Kobayashi described the generation 
of a hypervalent dimethylformamide-trichlorosilane complex and its effectiveness 
as a mild reducing agent for ketimines (Scheme 1.10).
[50] 
 
N HN
*
DMF, HSiCl3
51 52  
Scheme 1.10: Reduction of ketimines with DMF-trichlorosilane. 
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  In a similar manner, Matsumura investigated the potential of pyrrolidine 
derived formamides as catalytic Lewis basic activators for the reduction of prochiral 
ketimines  with  trichlorosilane.
[57]    Formamide  35  was  shown  to  be  much  more 
effective than DMF for the achiral reaction, generating amine 52 in 79% yield.  By 
employing enantiomerically pure formamides 36 and 37, a small range of ketimines 
were reduced to the corresponding chiral amines in moderate enantioselectivity 
(Table 1.9).   
 
Entry Catalyst
N
Me Ar
R
NH
Me Ar
R
HSiCl3
Catalyst
Ar R Yield (%) ee (%)
1
2
3
35
36
37
Ph Ph 79 NA
Ph Ph 91 55 (R)
Ph Ph 52 66 (R)
 
Table 1.9: Reduction of ketimines with pyrrolidine derived formamides. 
 
  In a modification of the chiral scaffold developed by Matsumura, Malkov 
and  Kocovsky  reported  valine  derived  formamides  as  highly  selective 
organocatalysts for the reduction of ketimines with trichlorosilane (Chart 1.8).
[58]  
Replacing the rigid cyclic core of the pyrrolidine formamides with a more flexible 
skeleton resulted in much higher levels of enantiodiscrimination; presumably as the 
more flexible system allows the catalyst to adopt a more favourable geometry in 
the transition state.  Although both 37 and valine derived formamide 54 have the 
same  absolute  configuration,  the  latter  results  in  formation  of  the  opposite 
enantiomer.   
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N
O
HN
O
H
R
N
O
HN
O
H
R
R
N
O H
N
O H
N
O H
H
N Ph
H
N
O O
N HO2C
Et
Et
Et O
35 36 37 38
53 R = H
54 R = Me
55 R = C6H11
56 R = t-Bu
57 R = CH3
58 R = CH2Ph
59 R = Ph
Chart 1.8: Formamide containing organocatalysts for reduction of ketimines 
   
  A range of prochiral ketimines were reduced with 53 and 54 as a catalyst 
(Table 1.10, entries 1 - 5); tuning the steric properties of the aromatic ring of the 
catalyst, as in 54, improved the reactivity.  It was found that selectivity was only 
observed with N-aryl imines.  In addition, non-polar solvents proved to be superior 
in terms of reactivity and enantioselectivity, with chloroform and toluene as the 
optimum.  Variation of the amino acid side-chain showed that bulkier groups such 
as cyclohexyl and t-butyl groups, 55 and 56, exhibited marginally reduced selectivity 
(Table 1.10, entries 6 and 7), while catalysts derived from alanine, phenylalanine 
and  phenylglycine,  57,  58  and  59,  were  considerably  less  selective  (Table  1.10, 
entries 8 – 10).   
  It  was  proposed  that  activation  of  trichlorosilane  occurs  through 
coordination to the formamide moiety in 54, it was also conjectured that the amide 
oxygen may play a role in coordinating silicon.  Arene-arene interactions between 
the catalyst and the N-aryl moiety of the imine were suggested as contributing to 
the enantiodifferentiating process.  The chirality of the amino acid side-chain is 
thought to be transmitted through the N-Me moiety of the catalyst. 
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Entry Catalyst Ar R Solvent Yield (%)
1
ee (%)
53 Ph Ph CHCl3 49 92 (S)
2a 54 Ph Ph CHCl3 94 92 (S)
3 54 Ph Ph Toluene 81 92 (S)
4 54 Ph PMP Toluene 85 91 (S)
5 54 Ph Bn Toluene 48 8
6 55
7 56
8 57
58
59
9
10
Ph PMP Toluene 95 82 (R)
Ph PMP Toluene 95 83 (S)
4-CF3C6H4 Ph Toluene 92 38 (R)
Ph PMP Toluene 84 49 (S)
Ph PMP Toluene 76 0
a Reaction carried out at -20 oC
N
Ar
R
HN
Ar
R
*
Catalyst 10 mol%
HSiCl3, 16h, rt
 
Table 1.10: Reduction of ketimines with amino acid derived formamides. 
 
  A range of formamide derived organocatalysts were developed by Sun, 60 – 
63, and shown to be effective for the reduction of ketimines with trichlorosilane 
(Chart  1.9).
[53,59-61]    The  most  successful  was  shown  to  be  63,  a  formamide 
derivative of L-pipecolinic acid.  Similar to the reactivity of ketones (Table 1.7), 
formamide  63  effectively  reduced  not  only  aromatic  ketimines,  but  aliphatic 
ketimines as well, in high yield and selectivity (Table 1.11).  Sun suggested that the 
reaction could not proceed through the analogous transition state as for ketone 
reduction  (Figure  1.6)  due  to  steric  repulsion  between  the  N-aryl  moiety  and 
catalyst methoxy group.  Instead it was suggested that the reduction of ketimines 
proceeds via a hexacoordinate silicon species (Figure 1.8).   
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N
H
S
O OH
F
N
N
O H
H
N
Ph
O
N
O H
H
N
O
N
O H
H
N
O
SO2(p-tBuPh)
Ph
O Ph
Ac
Ph
O Ph
Me
60 61 62 63
Chart 1.9: Organocatalysts developed by Sun. 
 
 
Si
Cl
O
Cl H
O Cl H
N
H
N
N R
Ph
Ph
O Me
Ar
 
Figure 1.8: Proposed transition state for reduction of ketimines with 63. 
 
 
N
R
Ar
HN
R
Ar
Entry R Ar Yield (%) ee (%)
1 Ph Ph 94
2 Ph PMP 93 89 (R)
3 4-MeO-C6H4 Ph 96
4 4-CF3-C6H4 Ph 98
5 c-C6H11 Ph 93
6 i-Pr Ph 93
93 (R)
93 (R)
88 (R)
92 (R)
89 (R)
Toluene, -20 oC
HSiCl3
Catalyst 63
10 mol %
 
Table 1.11: Reduction of ketimines with formamide 63. 
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1.4.3 Oxazoline Promoted Reduction 
 
  In conjunction with their studies of pyridine-oxazoline promoted reduction 
of ketones, Malkov and Kocovsky described the reduction of ketimines with catalyst 
47.
[54]  A small range of aromatic ketimines were converted to their corresponding 
amines in high enantioselectivity (≤87%, Table 1.12).  A similar mechanism to the 
reduction  of  ketones  was  proposed,  with  the  N-aryl  moiety  replacing  Cl3SiH 
coordinated to oxygen in the transition state (Figure 1.9).   
 
 
Entry
N
Me Ar
HN
Me Ar HSiCl3
Catalyst
Ar R Yield (%) ee (%)
1
2
3
Ph Ph 65 87
Ph PMP 60 85
67 86 PMP 2-naphth
*
R R
 
Table 1.12: Reduction of ketimines with pyridine-oxazoline 47. 
 
 
N N
O Ph
H Si
Cl
Cl Cl
H
Me
N
*
Ar
 
Figure 1.9: Proposed transition state for reduction of ketimines with 47. 
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1.5 Conclusions 
 
  The  past  decade  has  seen  considerable  advancement  in  the  field  of 
organocatalysis.  A vast number of small organic molecules have been reported as 
catalytic  activators  of  asymmetric  organic  reactions.    A  number  of  these 
organocatalysts may offer a viable alternative to traditional metal based catalysis 
due to the reported high yields and high enantioselectivity.    Although  some 
organocatalysts may have some foreseeable industrial or commercial applications 
the field still suffers from several drawbacks. 
  Many  organocatalysts  are  reaction  specific  and  subtle  changes  in  the 
catalytic  structure  can  often  render  the  organocatalyst  completely  inactive.  
Although general structural motifs can be identified and used as building blocks for 
new  organocatalysts  there  are  few  examples  of  general  organocatalysts.    Only 
proline  seems  to  have  any  great  ability  to  be  active  for  a  number  of  different 
reactions, however even proline is limited to reactions involving an enamine as the 
reactive species. 
  Substrate specificity is another drawback of contemporary organocatalytic 
reactions.    With  the  exception  of  formamides  23  and  43;  the  organocatalysts 
reviewed within are dependant on aromatic substrates to obtain good selectivity.  
In addition high catalytic loadings are often required compared to those used by 
metal catalysts. 
  These  drawbacks  can  be  capitalised  on  to  improve  the  field  of 
organocatalysis.  By endeavouring to develop more active organocatalysts it may be 
possible  to  lower  catalyst  loadings,  improve  substrate  tolerance  and  increase 
crossover between different reactions.  In this way it should be possible to make 
organocatalysis a practicable alternative to metal based catalysis. 
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2 Bifunctional Organocatalysts   
2.1 Introduction 
 
  Organocatalysts can act by coordination/activation of substrate or reagent 
as discussed above.  However another class of organocatalysts exists, which may 
activate  both  reagent  and  substrate  at  the  same  time.    These  bifunctional 
organocatalysts allow the substrate and the reagent to be brought close together 
and  held  in  a  specific  geometry,  mimicking  the  closed  transition  states  of 
intramolecular reactions.  In this way, the use of bifunctional organocatalysts often 
exhibits  a  greater  stereocontrol  and  an  improved  reactivity  compared  to 
monodentate organocatalysts. 
  The simple amino acid proline has emerged in recent years as one of the 
most effective organocatalysts for a wide number of bond forming reactions, in 
particular at the position α to the carbonyl group in aldehydes and ketones.
[9,18,62]  It 
is now widely accepted that proline acts as a bifunctional organocatalyst involving 
both amine and carboxyl groups in the reaction pathway.
[63]  The amine group is 
involved  in  generation of  a  nucleophilic  enamine  intermediate  after undergoing 
condensation with the carbonyl group of the substrate.  The electrophile is then 
activated  towards  the  nucleophilic  attack  by  the  enamine  by  H-bonding  to  the 
carboxylic  acid  group  (Scheme  2.1).    In  this  way,  dual  activation  of  both  the 
nucleophile  and  electrophile  by  the  same  molecule  has  led  to  the  impressive 
generality of proline catalysis. P a g e  | 31 
 
N
H
CO2H
O
R'
R
N CO2H
R'
R
Y
X H
N
Z
R
R' O O
Y
X H
N
Z
R
R' O O
X
Y
Z
O
R'
Y
Z
XH
R
H2O
H2O
electrophile
 
Scheme 2.1: Proposed mechanism for proline-catalysed conversions 
 
  A similar strategy has also been used in the stereoselective silylation of diols 
by exploiting the ability of silicon to form hypervalent species.
[12,64]  Hoyveda and 
Snapper  et  al.  developed  a  simple  amino  acid  based  bifunctional  catalyst  for 
selective  silylation  of  diols.
[65,66]    Lewis  basic  sites  incorporated  in  the  catalyst 
structure,  a  secondary  amine  and  amide  oxygen,  allow  the  substrate  diol  to 
coordinate  to  the  catalyst  backbone.    Generation  of  the  activated  hypervalent 
silicon  species  is  mediated  by  the  N-methylimidazole  group  integrated  into  the 
catalyst framework (Figure 2.1).  This facilitates quasi-intramolecular transfer of the 
electrophilic silicon moiety to the hydroxyl group.
[66] 
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Figure 2.1: Proposed mechanism of catalyst activation of silanes and diols. 
 
  Inspired  by  this  we  sought  to  develop  a  range  of  novel  bifunctional 
organocatalysts. 
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2.2 Target Compounds 
 
  Amino acids are among the simplest chiral frameworks and as such were 
chosen as the foundation for the new organocatalysts.  The naturally occurring α-
amino  acids  are  widely  available  and  are  relatively  cheap.    In  addition  both 
enantiomers are easily obtainable and many unnatural analogues are also available.   
Amino acids lend themselves to synthesis of bifunctional catalysts as they bear both 
an amino group and a carboxyl group making them easy to derivatise.  The chiral 
core would accommodate a formamide group for coordination of silane reagents.  
Substrate coordination would be achieved by incorporation of a group capable of 
hydrogen bonding to oxygen or nitrogen; in our case a thiourea or amide moiety.  
As we intend to carry out reactions on aromatic ketones or imines, an aromatic 
group would also be present to aid organisation of the organocatalyst and substrate 
through possible π-π interactions (Scheme 2.2).  
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Scheme 2.2: Planned mechanism of action for bifunctional organocatalysts. P a g e  | 34 
 
2.3 Synthesis 
 
  The initial targets were identified as compounds 64 to 66 (Chart 2.1).  The N-
α-methyl group on target 64 is required to transmit the chirality of the amino acid 
scaffold  closer  to the  reaction  centre.
[67]    In target  65 this  methyl  group  is not 
required as the formamide moiety is not adjacent to the chiral group.  Imidazole is a 
known  activator  of  silanes
[11]  and  as  such,  histidine  based  catalyst  66  offers  an 
additional coordination point for a silicon reagent.  Methylation of the imidazole 
ring proved to be necessary as previous tests demonstrated that N-α-Boc-histidine 
formed an insoluble complex with trichlorosilane.   
 
N
H
N
H
N
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NH
O
O
N
H
N
N
N
H
H
N O
N
H
S π
τ
64 65 66
Chart 2.1: Target organocatalysts. 
 
It is known that direct ring alkylation of histidine usually results in a mixture 
of  τ(N-1)  and  π(N-3)  alkylated  products.
[68]    Generally  alkylation  at  the  τ(N-1) 
position is carried out by first protecting the π(N-3) position, as exemplified by 
Beyerman.
[69]  A recent report, however, showed that at low temperature N-α-Boc-
histidine underwent selective deprotonation at the τ-(N-1) position using NaH in 
DMF,
[70]  which upon  reaction  with  alkyl  halides  produced  exclusively τ-alkylated 
products.  Following this protocol, N-α-Boc-N-τ-methyl-histidine was obtained by 
deprotonation of N-α-Boc-histidine, 67, with NaH in acetonitrile at -15 
oC followed 
by reaction with methyl iodide.  The desired N-α-Boc-N-τ-methyl-histidine, 68, was 
isolated as pale yellow crystals in 66% yield (Scheme 2.3).  
Various coupling methods were tried to convert 68 to amide 69.  Coupling 
using the mixed anhydride method was unsuccessful.  Coupling using DCC under 
standard conditions resulted in formation of the desired amide, 69; however 69 P a g e  | 35 
 
was  found  to  be  inseparable  from  the  reaction  by-product,  DCU.  To  facilitate 
separation of the product from the coupling by-products, it was decided to switch 
to related carbodiimide EDC.HCL.  The resulting urea is water soluble and therefore 
ought to be easily separated from the amide product by extraction.  Carrying out 
the  coupling  step  using  EDC.HCL,  HOBT  and  NMM  resulted  in formation  of the 
desired amide, 69.  Purification was easily accomplished by aqueous extraction of 
the reaction by-products followed by column chromatography to furnish 69 in 65% 
yield. 
Further  investigation  showed  that  EDAC.HCl  could  be  utilized  without 
employing other reagents, such as HOBT and NMM, thus simplifying the reaction 
procedure.  The N-Boc group was then removed with TFA in CH2Cl2 and converted 
to the formamide, 66, using a mixture of acetic anhydride and formic acid.  The 
target catalyst, 66, was obtained in 59% yield. 
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H
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N HN
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Boc
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N
NaH, MeI
CH3CN, -15 to -5oC
EDAC.HCl
MeCN
66
67 68
69
66%
65% 59%  
Scheme 2.3: Synthesis of N-α-formyl histidine derivative. 
 
  Synthesis of thiourea derived catalyst 75 began with reduction of Boc-valine 
to afford 71, followed by N-Boc protection to generate N-Methyl-N-Boc valinol, 72, P a g e  | 36 
 
in  good  yield  (87%).    Conversion  of  the  alcohol  to  an  amine  was  achieved  by 
introduction of a phthalimide group via the Mitsunobu reaction.  This was then 
easily removed with hydrazine hydrate in ethanol to give the required amine, 73, in 
99%  yield  over  two  steps.    Treatment  of  the  free  amine  73,  with 
phenyisothiocyanate afforded thiourea 74 in good yield, 88%.  Deprotection of the 
amine  was  achieved  under  standard  TFA  conditions.    Formylation  with  acetic 
anhydride and formic acid unexpectedly yielded either trifluoroacetamide 75, or 
acetamide 76 (Scheme 2.4).  Since the deprotected amine was isolated as the TFA 
salt it was thought that this was interfering in the formylation reaction.  Washing 
the crude deprotection mixture with a basic solution would remove any TFA and 
allow formation of the formamide, however when this was attempted only the 
amine 77 was isolated after 24h (Scheme 2.5).  Attempts to generate the desired 
compound by treatment with acetic formic anhydride were also unsuccessful. 
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Scheme 2.4: Synthesis of valine-thiourea derivative. 
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Scheme 2.5: Attempted formylation of 74. 
  It  was  thought  that  formylation  of  N-methyl  valinol  instead  of  Boc 
protection would circumvent the problems with formylation later in the synthesis 
(Scheme 2.6).  Formylation of N-methyl valinol, 71, by refluxing overnight in ethyl 
formate afforded the desired product, 78, in excellent yield (99%).  The phthalimide 
group  was  then  introduced  using  the  Mitsunobu  protocol  however  it  was 
discovered that 79 was inseparable from the reaction by-products.  It was found 
that  to  successfully  synthesise  and  isolate  the  target  catalyst  64;  the 
deprotection/formylation  step  had  to  occur  between  the  Mitsunobu  and 
phthalimide  removal  steps.    N-Me-N-Boc  valinol  was  converted  to  phthalimide 
derivative 80  under Mitsunobu  conditions.    Deprotection  of  the  Boc  group  and 
formylation was carried out under standard conditions to afford 81.  Removal of the 
phthalimide group to reveal the amine 82 was effected with hydrazine in ethanol.  
Treatment of N-Me-N-formyl valamine 82 with phenylisothiocyanate yielded the 
desired compound 64 in 56% yield (Scheme 2.7). 
 
NH OH N OH N
O O
N
O
O
Ethyl formate
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Phth, PPh3
DEAD, THF
71 78, 99% 79  
Scheme 2.6: Alternative formylation protocol. 
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Scheme 2.7: Synthesis of thiourea derivative 64. 
 
  The  synthesis  of  thiourea  derivative  65  commenced  with  reduction  of  L-
valine,  83,  with  LiAlH4  (Scheme  2.7),  which  afforded  L-valinol,  84,  in  66%  yield.  
Protection  of  the  amine  was  carried  out  with  di-tert-butyl  dicarbonate  in  the 
presence of triethylamine, to afford the protected amino alcohol, 85, in 84% yield, 
which was then converted to the phthalimide derivative, 86, by Mitsunobu reaction 
in 48% yield.  Phthalimide deprotection by hydrazine hydrate in ethanol yielded the 
mono  protected  diamine  87.    The  formamide  derivative,  88,  was  obtained  by 
refluxing the mono protected diamine in ethyl formate.  The Boc group was then 
removed with a TFA/DCM mixture (1:2) and the amino formamide treated with 
phenylisothiocyanate to afford catalyst 65 in 12% yield from 88. 
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Scheme 2.8: Synthesis of thiourea derivative 65. 
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2.4 Application in Model Catalytic Reactions 
   
  Allylation of aldehydes and reduction of ketones and imines are reactions 
that can be carried out using silane reagents.
[18]  The synthetic versatility of the 
chiral  end-products  of  these  reactions  has  prompted  investigation  into  an 
organocatalytic protocol.  With this in mind it was proposed that the prospective 
catalysts  would  be  tested  in  the  reduction  of  ketones  and  ketimines  with 
trichlorosilane,  and  allylation  of  aldehydes  with  allyltrichlorosilane  respectively 
(Scheme 2.9). 
 
H
O OH
X XH
Cl3Si
HSiCl3
Catalyst
Catalyst
30 X = O
89 X = NAr
*
*
 
Scheme 2.9: Model catalytic reactions. 
 
  Reduction of acetophenone 29 and a simple ketimine with thiourea catalyst 
64 (20% catalyst loading) in both cases gave the product in 40% yield, however no 
enantioselectivity  was  observed.    Catalyst  65  proved  to  be  less  reactive  in  the 
reduction reactions, the observed yields were 20%, however some selectivity was 
observed for the reduction of acetophenone, 10% ee, highlighting the importance 
of having the thiourea moiety next to the stereogenic centre.  Reduction using 
histidine  catalyst  66  did  not  proceed  and  only  starting  material  was  isolated.  
Disappointingly,  none  of  the  catalysts  exhibited  activity  in  the  allylation  of 
benzaldehyde; only 5% product was isolated for catalysts 64 and 66.   P a g e  | 41 
 
Entry Catalyst Yield (%) ee (%)
1
2
3
64
66
65
X
64
O
N-PMP
N-PMP
N-PMP
O 65
4
5
40 -
40 -
20 10
20 -
- -
HSiCl3, CHCl3, -20 oC
Catalyst 20 mol% Ph Me
X
Ph Me
XH
*
 
Table 2.1: Reduction test reaction results. 
 
Entry Catalyst Yield (%) ee (%)
1
2
3
64
66
65
5
-
5
-
-
-
O
H Ph
OH
Ph
Cl3Si
DIPEA, CHCl3, -20 oC
Catalyst 20 mol%
*
 
Table 2.2: Allylation test reaction results. 
 
Although the thiourea catalysts were equally active for reduction of both 
ketones and ketimines the conversion was too low to be considered active enough 
to carry on.  It was thought that replacement of the thiourea-phenyl group with a 
3,5-trifluoromethylphenyl group would improve reactivity and selectivity through 
stabilisation of the thiourea conformation.   It has been shown that when the ortho 
hydrogen atoms are more positively polarized due to meta electron withdrawing 
groups they form hydrogen bonds to the sulfur atom hindering the rotation of the 
phenyl group (Scheme 2.10). This increases the rigidity of the structure and has 
been shown to increase the binding ability of the thiourea fragment.
[71,72]  Attempts 
to introduce the 3,5-bistrifluoromethylphenyl group to the catalyst, as in 90, did not 
yield enough material to be used. Histidine derived catalyst 66 was not considered 
promising enough to be carried on, thus alternative structural motifs were sought.   P a g e  | 42 
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Scheme 2.10: Attractive S-H interaction 
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2.5 Phosphoramide Targets 
 
  Phosphoramide groups can be used as a coordinating group alternative to 
formamides for activation of silicon reagents.  Our new catalyst design included this 
as well as an aromatic amide group to promote hydrogen bonding and possibly 
aromatic interactions between the catalyst and substrate.  A selection of intended 
catalyst structures is shown in Chart 2.2.  
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Chart 2.2: Phosphoramide based catalysts. 
 
Initial catalytic tests were carried out using catalyst 91 which was assessed 
in the reduction of 29 and 89 and the allylation of benzaldehyde 6.  Additionally 91 
was  also  tested  in  the  allylation  of  2-hydroxyphenyl  imine  97  following  the 
publications by Kobayashi
[73] and Tsoegova
[74] (Scheme 2.11).   
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Scheme 2.11: Test reactions for proposed phosphoramide organocatalysts. P a g e  | 45 
 
2.6 Synthesis 
 
  The  synthesis  of  valine-derived  organocatalysts  91  and  92  began  with 
coupling  of  N-Boc  valine,  70,  to  3,5-dimethylaniline,  99,  employing  the  mixed 
anhydride method to afford amide 100 (Scheme 2.12).  The resulting amide was 
then treated with TFA in DCM to remove the Boc protecting group.  Treatment of 
the  deprotected  material  with  diphenylphosphinic  acid  chloride  and 
dimethylphosphinic acid chloride yielded 91 and 92 respectively.  Ligand 93 was 
synthesised in an analogous manner with benzhydrylamine, both 92 and 93 were 
available in our lab.  Treatment of 2,2’dihydroxy biphenyl with trichlorophosphine 
afforded 101.  Ligand 94 was obtained by treating amide 100 with 101 after Boc 
deprotection (Scheme 2.12). 
  Catalyst  95  was  obtained  in  67%  yield  by  treating  valinol,  84,  with 
diphenylphosphinyl  chloride  (Scheme  2.13).    The  synthesis  of  catalyst  96 
commenced  with  conversion  of  racemic  binol  to  the  corresponding  phosphoryl 
chloride 102.  Treatment of 102 with (S)-methylbenzylamine, 103, generated the 
phosphoramide  96  in  70%  overall  yield.    Resolution  of  the  diastereomers  was 
carried out by recrystallisation from ethanol.  Finally, ligand 105 was synthesised 
from  enantiopure  diamine  104  and  diphenylphosphinylchloride;  recrystallisation 
from toluene afforded the pure phosphoramide in 72% yield (Scheme 2.13). P a g e  | 46 
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Scheme 2.12: Synthesis of Phosphorous containing ligands. P a g e  | 47 
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Scheme 2.13: Synthesis of diastereomeric phosphorous ligands. P a g e  | 48 
 
2.7 Allylation at C=N 
 
Allylation of imines is an important C-C bond forming reaction as it leads to 
the generation of chiral amines which represent synthetically useful intermediates 
for  many  applications.
[75,76]    However,  it  is  one  of  the  few  reactions  that  has 
remained solely in the realm of transition metal catalysis and to date there has 
been  no  publication  of  a  true  organocatalytic  reaction  for  the  allylation  of 
aldimines.
[2,18]    Recent  advances  are  pushing  closer  to  development  of  an 
organocatalytic  protocol  for  this  elusive  reaction.
[39,74]    Although  not  purely 
catalytic, some organic molecules have emerged as good activators of allylsilanes 
when employed in stoichiometric quantities.
[2,18,39,74] 
  Work  carried  out  by  Kobayashi  showed  that  allylation  of  acylhydrazones 
derived from aldehydes with allyltrichlorosilane could be achieved in the presence 
of neutral coordinate organocatalysts (NCOs).  It was shown that NCOs such as DMF 
and HMPA were able to efficiently promote the racemic reaction when used as 
solvent.
[39]  Further development identified sulfoxides as another NCO capable of 
promoting the reaction; in particular the use of a chiral sulfoxide resulted in an 
asymmetric reaction taking place.
[73]  By using chiral sulfoxide 107 at a loading of 
300  mol%,  chiral  amine  derivative  108  was  obtained  in  73%  yield  and  93%  ee 
(Scheme 2.14).  While N-acylhydrazones showed good reactivity in the allylation 
reaction, simple aldimines remained unreactive towards allyltrichlorosilanes.   
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H Ph
NHBz HN
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NHBz
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-78 oC, 1 h
108 73%, 93% ee 106
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Scheme 2.14: Asymmetric addition of allylsilanes to acylhydrazones with NCO’s. 
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  More  recently  a  chiral  bisformamide  109,  (Chart  2.3)  has  emerged  as  a 
stoichiometric activator for the allylation of simple aldimines.
[74]  Tsogoeva et al 
showed that aldimines derived from benzaldehyde and 2-aminophenol could be 
successfully converted to allylic amines by using allyltrichlorosilane in the presence 
of  bisformamide  109  in  conjunction  with  L-proline.    Homoallylic  amines  were 
formed in good yield (>89%) and high selectivity (≤85%), however 2 equivalents 
each of bisformamide 109 and L-proline are required (Table 2.3, entries 1 – 4).  It 
was suggested that proline forms a chiral silane reagent in situ, 113.  This silane 
complex is then able to coordinate both the imine through the aromatic hydroxyl 
group and bisformamide 109 to generate the chiral transition state (Figure 2.2).  In 
the absence of the 2-hydroxyl group no reaction occurs, supporting the interaction 
with silicon.  Further studies with monoformamides 110 (Chart 2.3) showed that 
the second formamide group is integral to the selectivity observed with 109
[77].  
Based  on  these  results,  Tsogoeva  proposed  a  transition  state  involving  a 
hexacoordinate silicon species.  It was suggested that the imine was activated by 
forming a bond with silicon through the ortho-hydroxy group; coordination of a 
formamide moiety to silicon results in a hypervalent silicon species with enhanced 
nucleophilicity (Figure 2.2). 
 
HN NH
O O
N N O O
H H
109
N
H O
O
N
H Ar
110a Ar = Ph
110b Ar = naphth  
Chart 2.3: Formamide catalysts developed by Tsogoeva. 
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X Yield (%) ee (%)
NO2
CF3
Cl
OMe
94
91
89
94
85
81
85
68
N
H
X
HO
HN
X
HO
Proline (2 eq), CH2Cl2
RT, 48h
SiCl3
Formamide (2 eq)
111 112
Entry
1
2
3
4
 
Table 2.3: Allylation of imines with allyltrichlorosilane and bis-formamide activator. 
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Figure 2.2: Transition state proposed by Tsogoeva 
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2.8 Applications in Model Catalytic Reactions 
 
  Phosphoramide 91 showed some promise in the allylation of aldimine 111 
with allyltrichlorosilane, forming the chiral amine in 51% yield and 40% ee with 
catalyst loading 20 mol% (Scheme 2.15).  Unfortunately, the catalyst 91 turned out 
to be inactive in the allylation of aldehydes or reduction of ketones and ketimines. 
 
 
Scheme 2.15: Organocatalytic allylation reactions with 91 as organocatalyst. 
 
  Variation in the temperature of the reaction identified room temperature as 
the  optimum  (Table  2.4).    Surprisingly,  when  the  reaction  mixture  was  cooled, 
selectivity  also dropped.    It  may  be  that  at  lower  temperatures  an  uncatalysed 
reaction  mechanism  may  be  favoured  over  the  more  selective  pathway.    The 
additive was found to be required for enantiodiscrimination (Table 2.5, entry 1).  A 
range of additives other than (L)-proline were also examined (Table 2.5).  In the 
presence  of  N-methyl  imidazole,  iso-propanol  and  dimethylaminopyridine  the 
desired sec-amine was formed in moderate yields however the enantioselectivity 
was much lower than that observed for proline (Table 2.5, entries 2-4).  In the case 
of (D)-proline (Table 2.5, entry 5), the opposite enantiomer of sec-amine 112 was 
formed in good yield (61%) and similar selectivity (38%), indicating that proline is 
involved in the enantiodifferentiation process in the transition state.  Additionally 
the allylation of 111 did not proceed in the absence of di-isopropylethylamine. 
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Entry Temperature (oC) Yield (%) ee (%)
1
2
3
-20
0
rt
N.A. N.A.
20 (S)
40 (S)
44
51
 
Table 2.4: Effects of temperature on catalytic allylation reaction. 
 
entry catalyst activator yield (%) ee (%)
1 91 none 44 0
2 91 NMI 58
3 91 iPrOH 59
4 91 (D)-proline 61
5 91 DMAP 20 0
13 (S)
11 (S)
38 (R)
 
Table 2.5: Activators for allylation reaction. 
 
After  identifying  a  set  of  optimum  conditions  a  range  of  other  chiral 
nitrogen-phosphorous ligands were tested in the allylation of aldimine 111 (Table 
2.6). 
A number of structural changes were made to the parent catalyst 91 (Chart 
2.2).  Posphinamide 92 where Ph2P moiety was replaced with Me2P resulted in a 
significant decrease in selectivity.  Likewise, phosphate derivative 93 was active, 
however not as selective as 91.  The important role of the aromatic amide moiety 
present in 91 was demonstrated by the reduced selectivity observed with catalyst 
95, which produced only racemic product.  Attempts to tune selectivity by replacing 
the phenyl group with a larger aromatic moiety 93 were unsuccessful, resulting in a 
marginal  drop  in  enantiodifferentiation.    Diastereomeric  phosphoramides  96, 
derived from BINOL and 105, did not succeed in the formation of 112, identifying 91 
as the superlative phosphoramide organocatalyst tested. P a g e  | 53 
 
Entry Catalyst Yield (%) ee (%)
1
2
3
4
5
6
91
92
93
94
95
96
0
0
0
40 (S)
7 (S)
30 (S)
7 105 0
51
70
54
0
0
0
0
N
H
HN Cl3Si
DIPEA, CHCl3
Catalyst 91 20 mol%
Proline 2.5 eq
112 111
HO HO
 
Table 2.6: Effects of catalyst structure variation on catalytic allylation reaction. 
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2.9 Summary 
 
  Design and synthesis of a number of potential bifunctional organocatalysts 
incorporating  imidazole,  thiourea  and  phosphoramide  moieties  was  successfully 
achieved.  The organocatalysts were tested in the allylation and reduction reactions 
of carbonyl compounds and imines. 
  The  greatest  success  was  achieved  by  valine  derived  phosphoramide  91 
which catalysed the allylation of imine 111 to homoallylic amine 112 in 40% ee with 
a  loading  of  20  mol%,  the  reaction  hitherto  reported  only  with  the  use  of 
stoichiometric  activators.    Our  other  bifunctional  ligands  did  not  show  much 
promise  in  the  model  test  reactions,  however  they  may  still  find  use  in  other 
catalytic processes, so further testing to reveal potential applications is required.  
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3 Quinoline Derived Organocatalysts 
 
3.1 Introduction and Target Compounds 
 
Reduction of prochiral ketones and imines is most commonly carried out in 
industry  via  asymmetric  hydrogenation.   However  this  method  is not free from 
problems, namely those associated with metal leaching, high pressure, and the cost 
of the catalyst and its regeneration.  The alternative metal-free protocols are rare, 
however high selectivity has been attained with the use of formamide derivatives 
and trichlorosilane.
[58] 
As  part  of  our  group’s  focus  into  Lewis-basic  activators  for  silanes,  (2-
pyridyl) oxazolines were identified as an efficient class of catalysts for the reduction 
of ketones with trichlorosilane.  A range of ketones were successfully converted to 
the corresponding secondary alcohols with high selectivity.
[54]  The initial results 
also showed the catalysts 45 and 46 were effective for the reduction of a small 
range of aromatic ketimines (Scheme 3.1).   
 
N
N
O N
N
O
Ph
Ph
O
X
OH
X
HSiCl3, CH2Cl2
Catalyst
45
29% conv
66% ee (R)
46
85% conv
78% ee (R)
*
 
Scheme 3.1: Reduction of ketones with 2-pyridyl oxazolines.   
 
Although catalyst 46 successfully reduced aromatic ketones and ketimines 
with high selectivity, in some cases it suffered from low conversion.  Subsequent 
studies  showed  that  the  catalyst  decomposed  under  the  reaction  conditions.  P a g e  | 56 
 
Bidentate coordination of the catalyst to trichlorosilane generates a hexacoordinate 
silicon species, 113; a chloride can then dissociate to form a stable pentacoordinate 
silicon species, 114.  In this species, the Lewis acidic silicon activates the oxazoline 
towards  nucleophilic  attack.    The  dissociated  chloride  is  able  to  attack  at  the 
benzylic position and leads to opening of the oxazoline ring, 115 (Scheme 3.2).  
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N
O
Ph
N
N O
Ph
Si
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Cl
Cl
Cl
N
N O
Ph
Si
H
Cl
Cl
Cl
N
N O
Si
H
Cl
Cl
Ph
N
HN O
Cl Cl
Ph
46 113 114
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Scheme 3.2: Decomposition of oxazoline derived catalyst. 
 
  Amide 116 was isolated from the reaction mixture and its structure was 
confirmed by spectroscopic data.  The susceptibility of the oxazoline 5-position to 
nucleophilic  attack  is  due  in  part  to  the  electronegativity  of  oxygen.    It  was 
proposed  that  replacing  the  oxazoline  moiety  with  thiazoline  would  prevent 
chloride promoted ring-opening as the decreased electronegativity of sulfur should 
reduce the propensity for nucleophilic attack at the benzylic position. Further, it 
was considered that replacement of oxygen with either an N-methyl group or a CH2 
group could also prevent ring-opening.   
 P a g e  | 57 
 
N
N
O
Ph N
N
X
Ph
N
N
Me
N
Ph
N
N
H2
C
Ph
N
N
S
Ph
N
N
S
Ph N
N
S
Ph
N
N
S
Ph
117 118 119
120 121 122  
Chart 3.1: Alternatives to the oxazoline moiety for prevention of ring-opening. 
 
  To this end, we identified structures 117 to 122 as alternatives to 46 that 
would not be as susceptible to ring opening (Chart 3.1).  Pyridine imidazoline 117 
was synthesized in our group and shown to be inferior to 46 as a promoter for the 
reduction of ketones.  Reduction of acetophenone 29 with 117 afforded alcohol 30 
in 17% conversion and 34% ee, compared with 40% conversion, 64% ee for the 
corresponding oxazoline under the same conditions.   
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3.2 Synthesis 
 
  The synthesis of (2-pyridyl) thiazoline derivatives 119 to 122 was based on 
generation  of  the  general  thioamide  124  through  coupling  with  mandelic  acid 
derivative 123 followed by cyclisation with mesyl chloride (Scheme 3.3). 
 
N
R H
N
OH
Ph
S
N
N
S
Ph
R MsCl, base
124 123
HO
Ph
NH2
125
 
Scheme 3.3: General method for formation of thiazoline via cyclisation. 
 
  Amino alcohol 123 was generated from mandelic acid in a two-step process, 
according to the protocol developed by Brunner.
[78] First, mandelic acid, 126, was 
converted to mandelamide 127 in 90% yield.  The resulting amide 127 was then 
reduced with lithium aluminium hydride in refluxing tetrahydrofuran to produce 
amino alcohol 123 in 84% yield (Scheme 3.4). 
 
Ph
HO
OH
O
Ph
HO
NH2
O
Ph
HO
NH2
1. AcCl, MeOH
0 oC - rt
2. NH4OH, MeOH
4 oC
LiAlH4, THF
reflux
127 90% 123 84% 126
Scheme 3.4: Synthesis of mandelic acid derived amino alcohol. 
  
Synthesis  of  pyridyl-thiazoline  derivative  119  began  with  generation  of 
thioester 129 from 2-chloromethylpyridine, 128, sulfur and methyl iodide in 51% 
yield.  The resulting thioester was then coupled with amino alcohol 123 in THF in 
the  presence  of  triethylamine.    Thioamide  130  was  isolated  in  78%  yield.  
Cyclisation  was  then  achieved  by  treating  thioamide  130  with  mesyl  chloride, 
furnishing pyridine-thiazoline 119 in 82% yield as a white crystalline solid (Scheme 
3.5).   P a g e  | 59 
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Scheme 3.5: Synthesis of 2-pyridyl thiazoline 
 
Synthesis of (2-quinolyl) thiazoline 122 was carried out in analogous manner 
to 119, beginning with generation of thioester 132 from 2-chloromethyl quinoline, 
131  (99%).    Thioester  132  was  then  coupled  with  amino  alcohol  123  to  yield 
thioamide 133 in 78% yield.  Cyclisation was again achieved by treating thioamide 
133 with mesyl chloride, furnishing 2-quinoline-thiazoline 122 as a black oil which 
yielded black crystals on recrystallisation from ethanol (77%, Scheme 3.6). 
 
 
N
Cl
N
SMe
S
N
H
N
S
1. DMF, S8, Et3N
2. MeI
Ph
OH
N
N
S
Ph
MsCl, Et3N
+
Ph
OH H2N
CH2Cl2
THF, Et3N
132 99%
133 78%
122 77%
131
123
 
Scheme 3.6: Synthesis of 2-quinolinyl thiazoline 
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Taking into account that 1-chloromethylisoquinoline is not readily available; 
1-isoquinoline  carboxylic  acid,  135,  was  identified  as  an  alternative  starting 
material. It was thought that coupling of the acid with amino alcohol 123 followed 
by thionation would result in the desired thioamide 136.  Lawesson’s reagent, 134, 
was chosen because it was shown to be superior to P2S5 for conversion of carbonyl 
groups  to  thiocarbonyl  groups  (Scheme  3.7).
[79,80]    Lawesson  also  showed  that 
HMPA  could  act  as  a  non-covalent  protecting  group  to  prevent  thionation  of 
alcohols,  thus  preventing  an  additional  two  steps  being  carried  out  to  prevent 
undesired thionation of the hydroxyl group.   
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Scheme 3.7: Mechanism of action of Lawesson’s reagent 
 
Coupling of 1-isoquinoline carboxylic acid, 135, with amino alcohol 123 was 
carried out using the mixed anhydride method and produced the amide 136 in 89% 
yield (Scheme 3.8).  Thionation of the amide with Lawesson’s reagent was carried 
out  in  HMPA;  however  conversion  to  the  desired  thioamide  137  was  very  low, 
furthermore it could not be isolated from the crude reaction mixture.  It is known 
that thionation with Lawesson’s reagent is very sensitive to solvent and depends on 
the substrate therefore it was decided to investigate influence of different solvents.  
Toluene is known to be an efficient solvent for thionation using Lawesson’s 
reagent and so was chosen as a starting point for solvent investigations.  As HMPA 
would not be employed, the hydroxyl was protected with a TBS ether to afford 138 P a g e  | 61 
 
(63%).    The  silylated  compound  was  then  subjected  to  Lawesson’s  reagent  in 
refluxing  toluene  overnight  after  which  successful  thionation  was  observed.  
Treatment  of  the  crude  reaction  mixture  with  acid  followed  by  column 
chromatography led to the isolation of desired catalyst 120 in 74% yield (Scheme 
3.8). 
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N
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136 89%
138 63% 120 74%
135 124
H
N
S
OH
137
2) HCl, H2O
Scheme 3.8: Synthesis of 1-isoquinoline thiazoline 
 
  Synthesis of catalyst 121 was first attempted employing the same method 
used for 1-isoquinoline derivative 120.  Coupling of 3-isoquinoline carboxylic acid 
139 to mandelamine 123 was achieved using the mixed anhydride method and the 
target molecule, 140, was isolated in 43% yield.  Protection of the hydroxyl group 
was then carried out with TBDMSCl furnishing the protected compound 141 in 59% 
yield.  On treatment with Lawesson’s reagent in refluxing toluene however, the only 
material recovered was amide 140 (Scheme 3.9).   P a g e  | 62 
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Scheme 3.9: Synthesis of 3-isoquinoline thiazoline, strategy 1. 
 
  An  alternative  strategy  beginning  with  3-methyl  isoquinoline  142  as  a 
precursor was employed (Scheme 3.10).  Conversion of 3-methyl isoquinoline, 142, 
to  thioester  144  was  achieved  by  chlorination  with  trichlorisocyanuric  acid  in 
refluxing  chloroform  followed  by  treatment  with  sulphur  and  methyl  iodide.  
Thioester 144 was then coupled to mandelamine 123 to produce thioamide 145 in 
50% yield.  Thioamide 145 was then treated with mesyl chloride in the presence of 
triethylamine  to  affect  cyclisation.    The  cyclisation  did  not  proceed  as  well  as 
anticipated, however enough of the target thiazoline 121 (5%) was isolated to allow 
catalytic screening (Scheme 3.10). 
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Scheme 3.10: Synthesis of 3-isoquinoline thiazoline, strategy 2.  
 
  To allow comparison with thiazoline catalyst, an oxazoline analogue 148 was 
prepared.
[54]  Synthesis of 1-isoquinoline oxazoline, 148, commenced with coupling 
of  1-isoquinoline  carboxylic  acid  146  to  mandelamine  123  using  the  mixed 
anhydride method.  The resulting amide 147 was formed in 89% yield and isolated 
as a white crystalline solid.  Amide 147 was then treated with mesyl chloride in the 
presence of triethylamine to affect cyclisation.  The desired 1-isoquinoline oxazoline 
148  was  recrystallised  from  ethanol  and  isolated  as  a  white  solid  in  95%  yield 
(Scheme 3.11).  
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Scheme 3.11: Synthesis of 1-isoquinoline oxazoline. 
 
  Finally, synthesis of pyrroline catalyst 118 was attempted.  It was proposed 
that intramolecular condensation of 1,4-amino-ketone 149 would yield the desired 
pyrroline 118.  Aldol condensation of 2-acetyl pyridine, 152, and benzaldehyde, 6, 
to  generate  151,  followed  by  Michael  addition  of  nitromethane,  would  form  a 
suitable starting material for formation of 1,4-amino-ketone 149 (Scheme 3.12). 
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Scheme 3.12: Retrosynthetic analysis of 2-pyridine pyrroline. P a g e  | 65 
 
  Synthesis of 2-pyridine pyrroline 118 commenced with aldol condensation 
of  acetyl  pyridine,  152,  and  benzaldehyde,  6,  in  aqueous  sodium  hydroxide  to 
afford 151 in 35% yield (Scheme 3.13).  Michael addition of nitromethane to 151 in 
methanol resulted in the nitro compound 150 (41%).  Reduction of the nitro group 
had to be  carried  out  selectively  to  prevent  unwanted reduction  of  the  ketone 
group. Initial reduction of the nitro group with SnCl2 did not result in formation of 
149 and only starting material was isolated.  Attempts to reduce 150 with NaBH4 or 
by hydrogenation were equally unsuccessful.  Further attempts at reduction with 
the more reactive species NiCl2/NaBH4 resulted in over-reduction to amino alcohol 
153.    Although  153  was  formed  in  98%  yield,  re-oxidation  to  the  ketone  was 
unsuccessful. 
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Scheme 3.13: Synthesis of 2-pyridine pyrroline 
 
  It  was  believed  that  protection  of  the  ketone  before  treatment  with 
NaBH4/NiCl2  would  prevent  over-reduction;  however  attempts  to  form  the 
protected ketone 154 were unsuccessful (Scheme 3.14).  We then attempted to re-
oxidise  the  fully  reduced  amino  alcohol  153,  first  protecting  the  amino  group.    
Attempts to protect the amino functionality with a Boc group, 156, in order to allow P a g e  | 66 
 
oxidation of the alcohol to ketone however, did not produce the desired products 
(Scheme 3.14). At this point the synthesis of 118 was discontinued. 
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Scheme 3.14: Protection of ketone and amino groups. 
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3.3 Applications in Organocatalytic Reduction Reactions 
 
Prospective  thiazoline  activators  119  to  122  were  tested  in  the 
organocatalytic  reduction  of  acetophenone  29  and  simple  ketimine  89  (Scheme 
3.15).  After completion the reaction mixtures were analysed by chiral GC and NMR 
to evaluate enantioselectivity and catalyst degradation.  
 
X XH
Thiazoline (20 mol%)
HSiCl3, CHCl3
29 X = O
89 X = N-PMP
*
 
Scheme 3.15: Model catalytic reactions. 
 
Pyridine  derived  thiazoline  119  showed  promising  initial  results; 
phenylethanol, 30, was obtained in 25% yield and 64% ee.  Chiral amine 89 was also 
isolated in reasonable yield, 29%, and selectivity of 28% ee (Table 3.1, entries 1 and 
2).  Analysis of the reaction mixture after work up by 
1H NMR showed that the 
thiazoline catalyst 119 had remained intact and was not degraded. However, the 
reactivity  of  the  thiazoline  catalyst  was  considerably  reduced  compared  to  the 
related oxazoline, 46. 
The  addition  of  further  steric  constraints  from  the  quinoline  and 
isoquinoline  fragments  reduced  the  activity  of  the  thiazoline  derived 
organocatalysts even further.  Thiazolines 120 and 122 derived from 1-isoquinoline 
and 2-quinoline were unsuccessful in the reduction of both ketones and ketimines.  
Thiazoline 121 obtained from 3-isoquinoline showed some activity in the reduction 
of  acetophenone  (~5%  conversion),  however  was  inactive  in  the  reduction  of 
ketimines  (Table  3.1).    Oxazoline  catalyst  148  however  performed  well  in  the 
reduction of both acetophenone 29 and ketimines (Table 3.1, entries 9 and 10) 
although some degradation product was observed.  It may be that 120 does not 
allow efficient coordination of the silane due to the extra aromatic steric constraints 
while the increased size of sulfur compared to oxygen, forced the rings out of plane P a g e  | 68 
 
in  the  case  of  122.    Thiazoline  121  may  allow  weak  coordination  to  the  silane 
however apparently it remains insufficient to successfully activate trichlorosilane 
towards reduction.   
 
Yield (%) ee (%) Entry Catalyst X
1
2
3
4
5
6
7
8
120
119
119
120
121
121
122
122
O
N-PMP
O
O
O
N-PMP
N-PMP
N-PMP
0
0
0
0
0
0
N.A.
N.A.
N.A.
N.A.
N.A.
N.A.
25 64
29 28
HSiCl3, CHCl3
Catalyst 
20 mol%
X XH
9 148 O 96a 81b
10 148 N-PMP 60 85b
aConversion determined by GC after standard reaction work-up; bpreviously reported results[54]
*
Table 3.1: Reduction with ligands 119 –122, 148. 
 
Based  on  these  results  it  is  believed  that  catalysts  120  and  122  do  not 
permit  favourable  coordination  of  the  silane  whereas  3-isoquinoline  derived 
catalyst  121  was  not  sufficiently  active  to  promote  reduction  of  ketones  and 
ketimines.  Pyridine thiazoline 119, although successful, proved to be too sluggish to 
be  further  investigated.    The  initial  results,  however,  show  that  1-isoquinoline 
oxazoline  148  is  a  superior  organocatalyst  for  the  reduction  of  ketones  and 
ketimines.  It was decided to carry out further studies with organocatalyst 148 in 
order to expand the substrate range and investigate the scope of the reaction. 
  A range of α-chloro and heterocyclic ketones and ketimines were subjected 
to  reduction  with  trichlorosilane  in  the  presence  of  oxazoline  148  (Table  3.2).  P a g e  | 69 
 
Ketones and imines derived from α-chloro acetophenone after reduction to the 
corresponding alcohols and amines can be cyclised into the corresponding epoxides 
and aziridines.  Reduction of heterocyclic ketones or imines allows easy generation 
of  chiral  alcohols  and  amines  finding  application  as  chiral  building  blocks  and 
synthetic intermediates in target synthesis.   
  Reduction of a range of ketones was carried out with 20 mol% of oxazoline 
catalyst 148 in CHCl3 using HSiCl3 as the reducing agent.  Only 2-acetylthiophene 
and 2-methyl-5-acetylfuran exhibited reasonable reactivity, although the resulting 
alcohols were found to be racemic (Table 3.2, entries 1 and 2).  Unfortunately, no 
product was formed with other ketones tried (Table 3.2, entries 3 – 8).  It is possible 
that the Lewis basic heteroatom in the tested heterocyclic ketones coordinates to 
silane  interfering  with  the  catalytic  process  and  preventing  reduction  from 
occurring. 
 
O
R
OH
R
R Entry Conversion (%) ee (%)
2-pyridine
4-pyridine
2-thiophene
2-thiazole
X X
Ph
2,5-dimethyl-3-furan
2-methyl-5-furan
1-(benzofuran-2-yl)
X
Cl
H
H
H
H
H
H
H
1
2
3
4
5
6
7
8
70
- -
Catalyst 148 20 mol%
HSiCl3
50
- -
- -
- -
- -
- -
0
0
9a 2-MeO-C6H4 H 50 87
10a 2-F-C6H4 H 35 70
11a Ph H 85 84
aPreviously reported results[54]
* CHCl3, -20 oC
Table 3.2: Reduction of prochiral ketones with thiazoline 148. 
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Figure 3.1: Proposed transition state for catalysts 119 – 122, 148 
 
  Reduction of prochiral imines was more successful.  It was carried out in 
CHCl3 with 20 mol% of oxazoline catalyst 148 using HSiCl3 as the reducing agent.  
Propiophenone was reduced in 90% yield and 79% ee (Table 3.3, entry1). Chiral α-
chloro amines were obtained in 88 to 89% ee and good yield; 47% to 90% (Table 
3.3, entries 2-4).  Furan and thiophene derived imines were successfully reduced in 
73% yield, 55% ee and 77% yield, 60% ee respectively (Table 3.3, entries 5 and 6).  
Even imine derived from pyridine was successfully transformed to its corresponding 
amine  in  41%  yield  and  82%  ee  (Table  3.3,  entry  7).    The  results  obtained  are 
consistent with our current theory of enantiodifferentiation (Figure 3.2).
[54] 
 
N N
O Ph
H Si
Cl
Cl Cl
H
Me
N
*
Ar
 
Figure 3.2: Proposed transition state for reduction of ketimines with 148. 
 
 P a g e  | 71 
 
R1 R2 Yield (%) ee (%)
phenyl CH2Cl
CH2Cl
CH2Cl
1-chloro-4-benzene
1-fluoro-4-benzene
2-furan Me
2-thiophene Me
phenyl Et
Entry
1
2
3
4
5
6
7
8
79
88
88
89
55
60
4-pyridine Me 82
N
R2 R1
PMP
HN
R2 R1
PMP HSiCl3, CHCl3
Catalyst 148
20 mol%
47
70
Me 75 88
77
90
41
73
90
*
2-pyridine
Table 3.3: Reduction of prochiral ketimines with oxazoline 148.   
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3.4 Summary 
 
  Thiazoline  catalysts  derived  from  2-pyridines  have  been  shown  to  be 
effective activators of trichlorosilane for the reduction of ketones and ketimines.  
The problem of chloride promoted ring opening of the catalyst can be successfully 
avoided however at the cost of catalyst activity and selectivity.   
  Due to the lower reactivity of the thiazoline catalysts, further investigation 
was carried out with oxazoline catalyst 148.  Catalyst 148 was shown to be an 
efficient  organocatalyst  for  the  reduction  of  a  range  of  ketimines  with  a  large 
substrate scope.  The reactivity observed was in line with our previous mechanistic 
proposals.   
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4 Experimental 
 
General Methods 
 
All  reactions  were  carried  out  under  an  inert  atmosphere  in  oven-dried 
glassware  unless  otherwise  stated.    Room temperature  refers  to  ambient  room 
temperature (20-22 
oC); 0 
oC refers to an ice slush bath.  Heated experiments were 
conducted using thermostatically controlled oil baths.  Reactions were monitored 
by Thin Layer Chromatography using aluminium backed silica gel 60 (F254) plates, 
visualised using UV254/286 nm and PMA, Dragendorf, Platinum and Ninhydrin dips as 
appropriate.  Flash chromatography was carried out using 60 Å silica gel as the 
stationary phase.   
Melting  points  were  determined  on  a  Kofler  block  and  are  uncorrected.  
Optical rotations were recorded in CHCl3 at 25 °C unless otherwise indicated, with 
an error of ≤±0.1.  The [α]D values are given in 10
-1 deg cm
3 g
-1.  The NMR spectra 
were  recorded  in  CDCl3, 
1H  at  400  MHz  and 
13C  at  100.6  MHz  on  a  Bruker 
Spectrospin 400 (400 MHz) spectrometer.  Chemical shifts are reported in δ units, 
parts per million with chloroform-d1 (δ 7.26, 
1H; δ 77.0, 
13C) as internal standard 
unless otherwise indicated.  Coupling constants (J) are measured in Hz and are 
unadjusted; therefore due to limits in resolution, in some cases there are small 
differences (<1 Hz) in the measured J value of some coupling constants.    The  IR 
spectra were recorded on a JASCO FT-IR spectrophotometer for a thin film between 
NaCl plates.  The mass spectra (EI, CI and/or FAB) were measured on a Joel JMS700 
spectrometer.   
  Enantiomeric excess was determined by chiral GC analysis (using a 
Hewlett  Packard  6890  Series  GC  system,  Hewlett  Packard  3395  integrator  and 
Supelco α-Dex
TM or Supelco β-Dex
TM column) or by chiral HPLC analysis (using a 
Hewlett Packard Agilent 1100 Series quarternary pump, vacuum degasser, diode 
array detector, manual injector and Hewlett Packard ChemStation).  The chiral GC 
and HPLC methods were calibrated with the corresponding racemic mixtures. P a g e  | 74 
 
  Imines  used  for  catalytic  reduction  reactions  were  available  in  the 
laboratory and were synthesised using known methods. 
 
Bifunctional Organocatalysts 
 
HN N
O
HN
S
1 2
3
4
5
6
7
8 9
10 11
12
10 11
 
 
(S)-(-)-N-Methyl-N-[2-methyl-1-[(3-phenyl-thioureido)-methyl]-propyl]-formamide 
(64):  To  a  solution  of  N-(1-Aminomethyl-2-methyl-propyl)-N-methyl-formamide 
(524 mg, 1.88 mmol) in CH2Cl2 was slowly added phenylisothiocyanate (0.26 mL, 2.0 
mmol).  The reaction mixture was allowed to stir at room temperature overnight.  
The solvent was then removed in vacuo.  The crude mixture was then purified on a 
column of silica gel with a CH2Cl2-MeOH mixture (5:1) to afford 64 as a colourless oil 
(56%): [α]D -65.20 (c = 0.75, CHCl3/MeOH, 3:1); 
1H NMR (400MHz, CDCl3) δH 0.78 
(3H, d, J3-H,4-H = 6.4 Hz, 4-H), 0.93 (3H, d, J3-H,5-H = 6.2 Hz, 5-H), 1.65 – 1.74 (1H, m, 3-
H), 2.61 (3H, s, 7-H), 3.63 - 3.70 (2H, m, 1-H), 4.10 – 4.17 (1H, m, 2-H), 7.08 – 7.14 
(2H, m), 7.29 – 7.45 (2H, m), 7.54 (1H, bs); 
13C NMR (100MHz, CDCl3) δC 16.7 (CH3, 
4-C), 19.0 (CH3, 5-C), 27.7 (CH, 3-C), 32.5 (CH3, 7-C), 42.7 (CH2, 1-C), 64.9 (2-C), 124.8 
(CH), 126.6 (CH), 129.4 (CH), 137.2 (C, 9-C), 175.9 (CH, 6-C), 182.2 (C, 8-C); MS CI 
m/z (%) 280.3 (100, M+H), 246.3 (44), 218.3 (18), 163.1 (38), 145.2 (30); HRMS (CI) 
280.1484 (C14H22N3OS requires 280.1483. 
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(S)-(-)-N-[3-Methyl-2-(3-phenyl-thioureido)-butyl]  formamide  (S)-(-)-65:  (S)-88 
(736 mg, 3.2 mmol) was dissolved in a CH2Cl2-TFA (2:1) mixture (15 mL) and stirred 
at room temperature for 1 h.  The reaction mixture was then poured into saturated 
NaHCO3 solution (25 mL) and extracted with CH2Cl2 (3 x 20 mL).  The aqueous layer 
was then evaporated to dryness and the resulting solid extracted three times with 
CH2Cl2.  The organic layer was concentrated in vacuo and the residue dissolved in 
dry CH2Cl2 to which was added phenyl isothiocyanate (0.4 mL, 3.3 mmol) and the 
reaction was allowed to stir at room temperature overnight.  The solvent was then 
removed in vacuo and the crude residue purified on a column of silica gel with a 
Petrol  –  EtOAc  mixture  (3:2).    The  product  was  then  recrystallised  from 
hexane/EtOAc to afford (S)-(-)-65 as an off white solid (100 mg, 12%): [α]D -96.6 (c 
1.0, CHCl3); 
1H NMR (400 MHz, CDCl3) δH 0.81 (d, J4-H,3-H = 7.1 Hz, 3H, 4-H), 0.88 (d, 
J5-H,3-H = 6.8 Hz, 3H, 5-H), 1.75 – 1.81 (m, 1H, 3-H), 3.18 – 3.23 (m, 1H, 1α-H), 3.45 – 
3.49 (m, 1H, 1β-H), 4.06 – 4.22 (m, 1H, 2-H), 5.99 (d, J = 9.1 Hz, 1H, 2-NH), 6.52 (bs, 
1H, 1-NH), 7.16 (d, J = 8.3 Hz, 2H), 7.24 – 7.35 (m, 1H), 7.37 – 7.42 (m, 1H), 8.12 (s, 
1H, 6-H); 
13C NMR (100MHz, CDCl3) δC 18.3 (CH3, 4-C), 19.3 (CH3, 5-C), 30.8 (CH, 3-
C), 41.5 (CH2, 1-C), 59.5 (CH, 2-C), 125.7 (CH), 127.9 (CH), 130.3 (8-C), 130.4 (CH), 
161.9 (6-C), 181.69 (7-C). 
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(S)-N-(3,5-Dimethyl-phenyl)-2-formylamino-3-(τ-methyl-1H-imidazol-4-yl)-
propionamide  (S)-66:    A  solution  of  (S)-69  and  trifluoroacetic  acid  (5  mL)  in 
dichloromethane (5 mL) was stirred at room temperature for 1 h. The solvent was 
evaporated in vacuo and the crude TFA salt was dissolved in formic acid (5 mL).  
Acetic anhydride (2.5 mL) was added and the solution was allowed to stir at room 
temperature for 72 h. The mixture was then evaporated to dryness and the crude 
product was purified by chromatography on a column  of silica gel (60g) with a 
CH2Cl2–MeOH mixture (5:1) to afford (S)-66 (100 mg, 59%) as an orange solid: [α]D 
0.0 (c 1.0, CHCl3)
[81]; 
1H NMR (400 MHz, CDCl3) δH 2.21 (6H, s, 15-H), 2.94 (1H, dd, 
J3α-H, 3β-H  = 15.2 Hz, J3α-H, 2-H = 7.2 Hz, 3α-H), 3.11 (1H, dd, J3α-H, 3β-H = 15.2 Hz, J3β-H, 2-H 
= 4.0 Hz, 3β-H), 3.59, (3H, s, 10-H), 4.77 (1H, bd, J3β-H, 2-H = 4.0 Hz, 2-H), 6.66 (1H, s, 
5-H), 6.73 (1H, s, 7-H), 7.10 (2H, s, 12-H), 7.39 (1H, s, 14-H), 7.64 (1H, bs, 2-NH), 8.24 
(1H, s, 1-NH), 9.83 (1H, bs, 9-H); 
13C NMR (100 MHz, CDCl3) δC 21.4 (CH3, 15-C), 29.7 
(CH2, 3-C), 33.7 (CH3, 10-C), 52.5 (CH, 2-C), 117.6 (CH, 5-C), 118.3 (CH, 7-C), 126.0 
(CH), 138.6 (C), 161.4 (CH), 168.82 (9-C); IR (NaCl) ν 3019, 2399, 1215 cm
-1; MS (CI) 
m/z (%) 318.29 (100, M + NH4). 
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(S)-(+)-N-τ-Me-N-α-Boc-Histidine  (S)-(+)-68
[70]:  Sodium  hydride  (705  mg,  29.4 
mmol) was placed in a two-neck flask, flushed with Ar, washed 3× with petroleum 
ether,  and  dried  under  vacuum.  The  dry  NaH  was  then  added  slowly  to  a 
suspension of N-α-Boc-histidine 67 (2.5 g, 9.8 mmol) in CH3CN at –15 
oC and stirred 
for 30 min. Methyl iodide (1.53 g, 10.7 mmol) was added and the reaction mixture 
was then heated to –5 
oC and allowed to stir overnight at this temperature. The 
reaction was quenched with excess MeOH and the solvent was removed on a rotary 
evaporator.  The  resulting  solid  was  then  extracted  with  CHCl3  (3  ×  50  mL),  the 
solvent was evaporated and the resulting solid was purified by chromatography on 
a column of silica gel (50g), with a CH2Cl2–MeOH mixture (5:1), to give N-τ-Me-N-α-
Boc-Histidine (S)-(+)-68 as a pale yellow solid (1.64 g, 66%): mp (decomposition) 
166-168 
oC; [α]D
25 +29.5 (c 1.0, CHCl3); 
1H NMR (400 MHz, DMSO-d6) δH 1.36 (9H, s, 
11-H) 2.82 (2H, d, J = 4.8 Hz, 3-H) 3.56 (3H, s, 12-H) 3.91 (1H, bs, 2-H) 6.17 (1H, d, J = 
5.6 Hz, 5-H), 6.77 (1H, s, 7-H) 7.49 (1H, s, NH) in accordance with literature.
[70] 
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(S)-(+)-[1-(3,5-Dimethyl-phenylcarbamoyl)-2-(1-methyl-1H-imidazol-4-yl)-ethyl]-
carbamic acid tert-butyl ester (S)-(+)-69:  P a g e  | 78 
 
 
Mixed anhydride method: 
N-τ-Me-N-α-Boc-Histidine (S)-(+)-68 (600mg, 2.3 mmol) and triethylamine (0.38 mL, 
2.8 mmol) were dissolved in THF and cooled to 0
oC.  Methylchloroformate (0.27 mL, 
2.8mmol) was then added drop wise and the reaction allowed to stir for 1 hour.  
The precipitate was then filtered off.  Triethylamine (0.38 ml, 2.8 mmol) and 3,5-
dimethylaniline (0.35 ml, 2.8 mmol) were added and the reaction mixture left to stir 
overnight.  No product was observed. 
 
DCC Coupling Method: 
N-τ-Me-N-α-Boc-Histidine (S)-(+)-68 (200 mg, 0.76 mmol) was dissolved in CH2Cl2 
and a solution of DCC (190 mg, 0.92 mmol) in CH2CL2 (2 mL)  was added.  3,5-
dimethylaniline (130 mg, 1.07 mmol) was slowly added and the reaction mixture 
was left to stir overnight.  Although formation of the desired product was observed, 
it was found to be inseparable from DCU, the reaction by-product. 
 
EDC.HCL Coupling Method: 
Prepared  by  modification  of  the  procedure  developed  by  Rosenberg.
[82]    3,5-
dimethylaniline (95 mg, 0.79 mmol) was dissolved in DMF (5 mL).  N-τ-Me-N-α-Boc-
Histidine (S)-(+)-68 (200 mg, 0.76 mmol), 1-hydroxybenzotriazole hydrate (233 mg, 
1.7 mmol) and 4-methylmorpholine (96 mg, 0.91 mmol) were added sequentially.  
The  reaction  mixture  was  then  cooled  to  –23 
oC,  1-(3-dimethylaminopropyl)-3-
ethylcarbodiimide  hydrochloride  (226  mg,  1.14  mmol)  added  and  the  reaction 
allowed to stir for two hours.  The reaction was then heated to room temperature 
and left to stir overnight.  The reaction mixture was then poured into saturated 
NaHCO3 solution and extracted 3x with EtOAc.  The organic layer was then washed 
with water and brine and dried over MgSO4.  The solvent was removed and the 
crude mixture purified by column chromatography (PE:EtOAc 5:1).  The product (S)-
(+)-69 was obtained as yellow crystals in 65% yield.  
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EDAC Coupling Method: 
3,5-Dimethylaniline, (472 mg, 3.9 mmol) was added to a solution of N-τ-Me-N-α-
Boc-Histidine (S)-(+)-68 (1.0 g, 3.9 mmol), in dry MeCN. The solution was cooled to 
0 
oC and EDAC.HCl (910 mg, 4.7 mmol) was added and the reaction mixture was 
allowed to stir at room temperature for 48 h.  The mixture was then poured into 
saturated NaHCO3 solution and extracted 3× with EtOAc. The organic layer was 
washed with water and brine and dried over MgSO4.  The solvent was evaporated in 
vacuo and the crude product was purified by chromatography on a column of silica 
gel (75g) with a CH2Cl2–MeOH mixture (5:1) to afford (S)-(+)-69 as a pale orange 
solid (896mg, 60%): [α]D +53 (c 1.0, CHCl3); 
1H NMR (400 MHz, CDCl3) δH 1.38 (9H, s, 
11-H), 2.20 (6H, s, 17-H), 2.91 (1H, dd, J3α-H, 3β-H = 15.6 Hz, J3α-H, 2-H = 6.4 Hz, 3α-H), 
3.05 (d, J3α-H, 3β-H = 15.6 Hz, J3β-H, 2-H = 2H), 3.64 (3H, s, 12-H), 4.46 (1H, s, 2-H), 6.23 
(1H, s,), 6.65 (1H, s, 5-H), 6.67 (1H, s, 7-H), 7.19 (2H, s, 14-H), 7.37 (1H, s, 16-H); 
13C 
NMR (100 MHz, CDCl3) δC 21.4 (CH3, 17-C), 28.3 (CH3, 11-C), 30.7 (CH2, 3-C), 33.4 
(CH3, 12-C), 50.4 (CH, 2-C), 80.0 (10-C), 117.6 (CH, 5-C), 118.6 (CH, 7-C), 125.9 (CH, 
16-C), 137.2 (CH, 14-C), 138.5 (15-C), 155.1 (9-C), 170.2 (1-C). 
 
 
NH OH
1
2
3
4
5
6
 
 
(S)-N-methyl valinol (S)-71: To a suspension of LiAlH4 (3.8 g, 0.1 mol) in THF (60 mL) 
at 0 
oC was slowly added N-Boc valine (5.0 g, 23.0 mmol) The reaction was allowed 
to stir at this temperature for 2h and was then heated overnight at 70 
oC.  The 
mixture was then cooled to 0 
oC, NaSO4.10H2O was added to remove excess LiAlH4 
and the mixture was then filtered through Celite.  The solvent was then removed in 
vacuo to afford N-methyl valinol as a colourless oil (2.36 g, 87%): 
1H NMR (400 MHz, 
CDCl3) δH 0.82 (3H, d, J4-H,5-H = 6.8 Hz, 4-H), 0.89 (3H, d, J4-H,5-H = 6.8 Hz, 5-H), 2.35 
(3H, s, 6-H), 3.26 (1H, dd, J = 7.2 Hz, J1α-H,1β-H = 10.8 Hz, 1α-H), 3.55 (1H, dd, J = 4.4 P a g e  | 80 
 
Hz,  J1α-H,1β-H  =  10.8  Hz,  1β-H),  3.69  (1H,  t,  J  =  6.8  Hz,  2-H)  in  agreement  with 
literature.
[83]  
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(S)-(-)-N-methyl-N-tert-butoxycarbonyl valinol (S)-72: To a solution of di-tert-butyl-
dicarbonate in CH2Cl2 (25 mL) at 0 
oC was added N-methyl valinol (2.36 g, 20.1 
mmol) and triethylamine (6.2 mL, 44.22 mmol).  The reaction mixture was allowed 
to warm to room temperature and left to stir overnight.  The reaction mixture was 
then acidified to pH 5 with 1M citric acid and extracted with CH2Cl2 (3 x 25 mL).  The 
organic phase was then dried over MgSO4 and evaporated to dryness.  The crude 
mixture was then purified on a column of silica gel with a Pet Ether-EtOAc mixture 
(2:1) to afford (S)-N-methyl-N-tert-butoxycarbonyl valinol as a colourless oil (3.8 g, 
87%): [α]D -25.00 (c = 1.0, CHCl3);  
1H NMR (400 MHz, CDCl3) δH 0.81 (3H, d, J4-H,5-H = 
6.8 Hz, 4-H), 0.90 (3H, d, J4-H,5-H = 6.8 Hz, 5-H), 1.47 (9H, s, 9-H), 1.8 (1H, m, 3-H), 
2.69 (3H, s, 6-H), 3.40 – 3.48 (1H, m), 3.60 – 3.69 (1H, m), 3.91 – 4.23 (1H, m); CI MS 
m/z (%) 218.2 (20, M+H), 162.1 (100), 118.2 (18); HRMS (CI+) 218.1756 (C11H24O3N 
requires 218.1758). 
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 (S)-(1-Aminomethyl-2-methyl-propyl)-methyl-carbamic  acid  tert-butyl  ester  (S)-
73: To a dry round bottomed flask was added phthalimide (2.04 g, 13.88 mmol), 
THF  (25  mL),  triphenylphosphine  (7.28  g,  27.75  mmol)  and  N-methyl-N-tert-
butoxycarbonyl valinol (2.0 g, 9.25 mmol) in that order.  The mixture was cooled to 
0
oC and diethylazodicarboxylate (4.02 g, 23.12 mmol) added.  The reaction mixture 
was warmed to rt and allowed to stir overnight.  The solvent was then removed in 
vacuo and the residue passed through a column of silica gel with a Pet Ether-EtOAc 
mixture (5:1).  
1H NMR (400 MHz, CDCl3) δH 0.78 – 1.19 (m, 15H), 1.72 (bs, 1H), 2.55 
(s, 3H), 3.61 – 3.72 (m, 2H), 3.95 (m, 1H), 7.52 – 7.61 (m, 2H), 7.70 – 7.80 (m, 2H). 
To a solution of the crude material in EtOH (5 mL) was added hydrazine hydrate 
(1.44 g, 45.0 mmol).  The reaction mixture was allowed to stir overnight at room 
temperature.  The reaction mixture was then filtered and washed with Et2O, the 
solvent was removed in vacuo to afford (1-Aminomethyl-2-methyl-propyl)-methyl-
carbamic acid tert-butyl ester as an off white solid (99%). 
1H NMR (400 MHz, CDCl3) 
δH 0.85 (3H, dd, J = 2.0 Hz, J = 6.4 Hz, 4-H), 0.99 (3H, dd, J = 6.0 Hz, J = 6.8 Hz, 5-H), 
1.49 (9H, s, 9-H), 1.65 (1H, m, 3-H), 2.73, 2.80 (2 x s, 2 x 3H), 2.93 (1H, dd, J = 4.4 Hz, 
J = 12.4 Hz, 1α-H), 2.98 (1H, dd, J = 3.6 Hz, J = 13.6 Hz, 1β-H), 3.78 (1H, m, 2-H). 
 
 
N HN
HN
S
O
O
1 2
3
4
5
6
7
8
9
10 11
12 13
14 9
9
12 13
 
 
(S)-(-)-Methyl-[2-methyl-1-[(3-phenyl-thioureido)-methyl]-propyl]-carbamic  acid 
tert-butyl ester (S)-74: To a solution of (1-Aminomethyl-2-methyl-propyl)-methyl-P a g e  | 82 
 
carbamic acid tert-butyl ester (S)-73 (1.61 g, 4.60 mmol) in Et2O was slowly added 
phenylisothiocyanate (676 mg, 5.0 mmol).  The reaction mixture was allowed to stir 
at room temperature overnight.  The solvent was then removed in vacuo and the 
crude product purified purified on a column of silica gel with a Pet Ether-EtOAc 
mixture (2:1) to afford (S)-74 (1.43 g, 88%) as a white solid: [α]D -29.9 (c = 1.0, 
CHCl3);  
1H NMR (400 MHz, CDCl3) δH 0.75 (3H, d, J4-H, 3-H = 6.8 Hz, 4-H), 0.95 (3H, d, 
J5-H, 3-H = 6.8 Hz, 5-H), 1.27 (9H, s, 9-H), 1.70 (1H, m, 3-H), 2.62 (3H, s, 6-H), 3.72 (2H, 
m, 1-H), 4.02 (1H, m, 2-H), 7.08 – 7.12 (2H, m, 12-H), 7.20 - 7.33 (3H, m, 13-H, 14-
H); CI MS m/z (%)  352.3 (82, M+H), 218.3 (100); HRMS (CI) 352.2059 (C18H30N3O2S 
requires 352.2061). 
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(S)-2,2,2-Trifluoro-N-methyl-N-[2-methyl-1-[(3-phenyl-thioureido)-methyl]-
propyl]-acetamide  (S)-75:  Methyl-[2-methyl-1-[(3-phenyl-thioureido)-methyl]-
propyl]-carbamic acid tert-butyl ester (S)-74 (98 mg, 0.28 mmol) was dissolved in a 
CH2Cl2-TFA (2:1) mixture (5 mL) and stirred at room temperature for 1 hour.  The 
solvent was then removed in vacuo.  The crude TFA salt was dissolved in formic acid 
(1 mL) and acetic anhydride (224 mg, 2.2 mmol) added and the reaction mixture 
was allowed to stir for 16h.  The solvent was then removed in vacuo and the crude 
residue purified on a column of silica gel with a Pet Ether – EtOAc mixture (2:1) to 
afford (S)-75 as a white solid (62 mg, 64%):  
1H NMR (400 MHz, CDCl3) δH 0.96 (3H, 
d, J4-H, 3-H = 6.8 Hz, 4-H), 1.05 (3H, d, J5-H, 3-H = 6.8 Hz), 2.05 (1H, m, 3-H), 2.56 (3H, s, 
6-H), 3.41 (1H, m, 1α-H), 3.51 (1H, m, 1β-H), 4.10 (1H, m, 2-H), 7.07 – 7.26 (5H, m), 
7.79 (1H, bs, 9-NH), 8.63 (1H, bs, 11-NH);  
13C NMR (100 MHz, CDCl3) δC 16.8 (CH3, 
4-C), 19.1 (CH3, 5-C), 27.7 (CH, 3-C), 32.4 (CH3, 6-C), 42.6 (CH2, 1-C), 64.9 (CH, 2-C), 
124.8 (CH), 126.5 (CH), 129.3 (CH), 137.3 (C), 162.5 (C, 7-C), 182.2 (C, 10-C). P a g e  | 83 
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(S)-N-Methyl-N-[2-methyl-1-[(3-phenyl-thioureido)-methyl]-propyl]-acetamide 
(S)-76:  Methyl-[2-methyl-1-[(3-phenyl-thioureido)-methyl]-propyl]-carbamic  acid 
tert-butyl  ester  (S)-74  (1.43  g,  4.07  mmol)    was  dissolved  in  a  CH2Cl2-TFA  (2:1) 
mixture (10 mL) and stirred at room temperature for 1 hour.  The solvent was then 
removed in vacuo.  The crude TFA salt was dissolved in formic acid (10 mL) and 
acetic anhydride (3.32 g, 32.6 mmol) added and the reaction mixture was allowed 
to stir for 16h.  The solvent was then removed in vacuo and the crude residue 
purified on a column of silica gel with a Pet Ether – EtOAc mixture (5:1) to afford N-
Methyl-N-[2-methyl-1-[(3-phenyl-thioureido)-methyl]-propyl]-acetamide  as  a 
yellow oil: 
1H NMR (400 MHz, CDCl3) δH 1.05 (3H, d, J4-H, 3-H = 6.8 Hz, 4-H), 1.12 (3H, 
d, J5-H, 3-H = 6.8 Hz, 5-H), 1.99 (3H, s, 8-H), 2.11 (1H, m, 3-H), 2.18 (3H, s, 6-H), 3.44 
(1H, bs, 1α-H), 3.62 (2H, m, 1β-H, 2-H), 7.17 – 7.41 (m, 5H), 8.29 (1H, bs, 9-NH), 8.61 
(1H, bs, 11-NH);
 13C NMR (100 MHz, CDCl3) δC 16.7 (CH3, 4-C), 18.9 (CH3, 5-C), 20.8 
(CH3, 8-C), 27.7 (CH, 3-C), 32.5 (CH3, 6-C), 42.7 (CH2, 1-C), 64.9 (CH, 2-C), 124.8 (CH), 
126.6 (CH), 129.4 (CH), 137.2 (C, 12-C), 175.9 (C, 7-C), 182.2 (C, 10-C); CI MS m/z (%) 
280.3 (100, M+H), 246.3 (43), 218.3 (28), 163.1 (38), 145.2 (30); HRMS (EI) 279.1405 
(C14H21ON3S requires 279.1404). 
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(S)-(-)-N-Methyl-N-formyl valinol (S)-(-)-78: N-Methyl valinol (1.64 g, 13.9 mmol) 
was dissolved in ethyl formate (10 mL) and allowed to reflux for 16h.  The solvent 
was  then  removed  in  vacuo  to  afford  N-Methyl-N-formyl  valinol  as  a yellow  oil 
(99%), which was carried on without purification: [α]D -16.80 (c = 1.0, CHCl3); 
1H 
NMR (400MHz, CDCl3) δH 0.88 (3H, d, J3-H,4-H = 6.4 Hz, 4-H), 1.00 (3H, d, J3-H,5-H = 6.4 
Hz, 5-H), 1.83 – 1.87 (1H, m, 3-H), 2.79 (3H, s, 7-H), 3.02 – 3.07 (1H, m, 2-H), 3.78 – 
3.82 (2H, m, 1-H), 8.03 (1H, s, 6-H). 
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(S)-N-[1-(1,3-Dioxo-1,3-dihydro-isoindol-2-ylmethyl)-2-methyl-propyl]-N-methyl-
formamide (S)-79:   
Method A: To a dry round bottomed flask were added phthalimide (3.07 g, 41.7 
mmol), THF (25 mL), triphenylphosphine (10.94 g, 20.85 mmol) and N-Methyl-N-
formyl valinol (3.81 g, 13.9 mmol) in that order.  The mixture was cooled to 0
oC and 
diethylazodicarboxylate (6.05  g,  34.75  mmol)  added.    The  reaction  mixture  was 
warmed to rt and allowed to stir overnight.  The reaction mixture could not be 
purified. P a g e  | 85 
 
Method B: [1-(1,3-Dioxo-1,3-dihydro-isoindol-2-ylmethyl)-2-methyl-propyl]-methyl-
carbamic acid tert-butyl ester (2.16 g, 6.26 mmol) was dissolved in a mixture of 
CH2Cl2-TFA (2:1, 10 mL) and stirred at room temperature for 1h.  The solvent was 
then removed in vacuo and the residue dissolved in CH2Cl2 (20 mL) and washed 
with  sat.  NaHCO3  (2  x  10  mL).    The  organic  phase  was  dried  over  MgSO4  and 
concentrated in vacuo.  The resulting solid was then dissolved in formic acid (10 mL) 
and acetic anhydride (5 mL, 50 mmol) added.  The reaction mixture was allowed to 
stir at room temperature overnight.  The solvent was then removed in vacuo and 
the residue purified on a column of silica gel with a Pet Ether-EtOAc mixture (2:1) to 
afford N-[1-(1,3-Dioxo-1,3-dihydro-isoindol-2-ylmethyl)-2-methyl-propyl]-N-methyl-
formamide (S)-79 as a white solid (1.03 g, 60%): 
1H NMR (400MHz, CDCl3) δH 0.94 
(d, J = 6.8 Hz, 3H), 1.19 (d, J = 6.4 Hz, 3H) 1.97 (m, 1H), 2.71, 2.93 (2 x s, 2 x 3H), 3.54 
(dt, J = 3.6 and 10.8 Hz, 1H), 3.7 – 3.9 (m, 2H), 7.58 – 7.82 (m, 5H). 
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(S)-[1-(1,3-Dioxo-1,3-dihydro-isoindol-2-ylmethyl)-2-methyl-propyl]-methyl-
carbamic acid tert-butyl ester (S)-80: To a dry round bottomed flask was added 
phthalimide (2.04 g, 13.88 mmol), THF (25 mL), triphenylphosphine (7.28 g, 27.75 
mmol) and N-methyl-N-tert-butoxycarbonyl valinol (2.0 g, 9.25 mmol) in that order.  
The mixture was cooled to 0
oC and diethylazodicarboxylate (4.02 g, 23.12 mmol) 
added.  The reaction mixture was warmed to rt and allowed to stir overnight.  The 
solvent was then removed in vacuo and the residue purified on a column of silica P a g e  | 86 
 
gel  with  a  Pet  Ether-EtOAc  mixture  (5:1).    After  column  chromatography  the 
product was not pure however further attempts at purification were not successful.  
1H NMR (400 MHz, CDCl3) δH 0.78 – 1.19 (15H, m, 4-H, 5-H, 9-H), 1.72 (1H, bs, 3-H), 
2.55 (3H, s, 6-H), 3.61 – 3.72 (2H, m, 1-H), 3.95 (1H, m, 2-H), 7.52 – 7.61 (2H, m, 13-
H), 7.70 – 7.80 (2H, m, 12-H). 
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(S)-N-[1-(1,3-Dioxo-1,3-dihydro-isoindol-2-ylmethyl)-2-methyl-propyl]-N-methyl-
formamide (S)-81:  (S)-80 (2.16 g, 6.26 mmol) was dissolved in a mixture of CH2Cl2-
TFA (2:1, 10 mL) and stirred at room temperature for 1h.  The solvent was then 
removed in vacuo and the residue dissolved in CH2Cl2 (20 mL) and washed with sat. 
NaHCO3 (2 x 10 mL).  The organic phase was dried over MgSO4 and concentrated in 
vacuo.  The resulting solid was then dissolved in formic acid (10 mL) and acetic 
anhydride (5 mL, 50 mmol) added.  The reaction mixture was allowed to stir at 
room temperature overnight.  The solvent was then removed in vacuo and the 
residue purified on a column of silica gel with a Pet Ether-EtOAc mixture (2:1) to 
afford N-[1-(1,3-Dioxo-1,3-dihydro-isoindol-2-ylmethyl)-2-methyl-propyl]-N-methyl-
formamide (S)-81 as a white solid (1.03 g, 60%): 
1H NMR (400MHz, CDCl3) δ 0.94 
(3H, d, J = 6.8 Hz, 4-H), 1.19 (3H, d, J = 6.4 Hz, 5-H) 1.95 – 1.98 (1H, m, 3-H), 2.71, 
2.93 (2 x 3H, 2 x s, 6-H), 3.54 (1H, dt, J = 3.6 and 10.8 Hz, 2-H), 3.7 – 3.9 (2H, m, 1-H), 
7.58 – 7.82 (4H, m, 10-H, 11-H). 
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(S)-N-(1-Aminomethyl-2-methyl-propyl)-N-methyl-formamide  (S)-82:  (S)-81  (516 
mg, 1.88 mmol) was dissolved in EtOH and hydrazine hydrate (302 mg, 9.45 mmol) 
added.  The reaction mixture was allowed to stir at room temperature overnight.  
The mixture was then filtered and the precipitate washed with Et2O.  The solvent 
was removed and the crude mixture carried on without purification. 
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(S)-Valinol (S)-84: To a suspension of valine 83 (10.04 g, 85.7 mmol) in THF (100 mL) 
at 0 
oC was slowly added LiAlH4 (6.7g, 0.18 mol).  The reaction was allowed to stir at 
this temperature or 2h and was then heated overnight at 70 
oC.  The mixture was 
then cooled to 0 
oC, NaSO4.10H2O was added to remove excess LiAlH4 and the 
mixture was then filtered through Celite.  The solvent was then removed in vacuo 
to afford (S)-valinol (5.81 g, 66%) as a pale yellow oil: 
1H NMR (400MHz, CDCl3) δH 
0.98 (3H, d, J4-H,5-H = 4.1 Hz, 4-H), 1.01 (3H, d, J4-H,5-H = 6.5 Hz, 5-H), 1.59 – 1.61 (1H, 
m,), 1.86 (3H, br s,), 2.54 – 2.57 (1H, m,), 3.32 (1H, m,), 3.66 (1H, dd, J = 3.95, 10.44 
Hz,) in accordance with literature.
[84] 
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(S)-(-)-N-tert-butoxycarbonyl valinol (S)-(-)-85:  To a solution of valinol (S)-84 (5.0 g, 
48.5 mmol) in CH2Cl2 (50 mL) at 0 
oC was added di-tert-butyl dicarbonate (12.7 g, 
58.15  mmol)  and  triethylamine  (13.5  mL,  96.9  mmol)  and  the  reaction  mixture 
allowed  to  stir  at  room  temperature  for  16  h.    The  reaction  mixture  was  then 
acidified to pH 5 with 2 M HCl and extracted with CH2Cl2 (3 x 25 mL).  The organic 
layer was then dried over MgSO4, filtered and concentrated in vacuo to afford N-
tert-butoxycarbonyl valinol (S)-(-)-85 (8.32 g, 84%) as a yellow oil; [α]D -15.0 (c = 2.0, 
CHCl3);  
1H NMR (400MHz, CDCl3) δH 0.84 (3H, d, J3-H,4-H = 7.6 Hz, 4-H), 0.90 (3H, d, J3-
H,5-H = 7.1 Hz, 5-H), 1.38 (9H, s, 8-H), 1.77 (1H, m, 3-H), 3.35 (1H, m, 2-H), 3.55 (1H, 
m, 1α-H), 3.63 (1H, m, 1β-H), 4.58 (1H, bs, NH); 
13C NMR (100 MHz, CDCl3) δC 18.6 
(CH3, 4-H), 19.5 (CH3, 5-H), 28.4 (CH3, 8-C), 29.4 (CH, 3-C), 46.2 (CH2, 1-C), 58.1 (CH, 
2-C), 85.2 (C, 7-C), 156.9 (C, 6-C) in agreement with literature values.
[85] 
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(S)-[1-(1,3-Dioxo-1,3-dihydro-isoindol-2-ylmethyl)-2-methyl-propyl]carbamic  acid 
tert-butyl ester (S)-86:  To a dry round bottomed flask was added phthalimide (4.51 
g, 30.68 mmol), THF (100 mL), triphenylphosphine (16.08 g, 61.3 mmol) and N-tert-
butoxycarbonyl valinol (S)-85  (4.15 g, 20.45 mmol) in that order.  The mixture was 
cooled  to  0 
oC  and  diethylazodicarboxylate  (8.04  mL,  51.0  mmol)  added.    The P a g e  | 89 
 
reaction mixture was warmed to room temperature and allowed to stir overnight.  
The solvent was then removed in vacuo and the residue purified on a column of 
silica gel with a Petrol-EtOAc mixture (5:1).  After column chromatography (S)-86 
was isolated (48%) but was not pure and further attempts at purification were not 
successful.  
1H NMR (400 MHz, CDCl3) δH 0.93 (3H, d, J3-H,4-H = 6.8, 4-H), 0.95 (3H, d, 
J3-H,5-H = 6.8, 5-H) 1.10 (9H, s, 8-H), 1.81 – 1.89 (1H, m, 3-H), 3.67 -3.74 (1H, m, 2-H), 
3.85 – 3.93 (2H, m, 1-H), 4.70 (1H, d, J = 9.8 Hz, NH), 7.67 – 7.77 (2H, m), 7.78 – 7.91 
(2H, m); MS CI m/z (%) 333.3 (M+H, 27), 277.2 (100), 233.2 (55), 172.3 (31). 
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(S)-1-amino-2-tert-butyl carbamate-3-methyl butane (S)-87: To a solution of crude 
(S)-86 in EtOH (10 mL) was added hydrazine hydrate (2.88 g, 90.0 mmol).  The 
reaction mixture was allowed to stir overnight at room temperature.  The reaction 
mixture was then filtered and washed with Et2O, the solvent was removed in vacuo 
to afford (S)-87 as an off white solid: 
1H NMR (400 MHz, CDCl3) δH 0.83 (3H, d, J3-H,4-
H = 6.8 Hz, 4-H), 0.86 (3H, d, J3-H,5-H = 6.8 Hz, 5-H), 1.38 (9H, s, 8-H), 1.67 (1H, m, 3-
H), 2.54 (1H, dd, J1α-H,1β-H = 13.1 Hz, J1α-H,2-H = 7.8 Hz, 1α-H), 2.73 (1H, dd, J1α-H,1β-H = 
13.1 Hz, J1β-H,2-H = 4.0 Hz, 1β-H), 3.30 – 3.35 (1H, m, 2-H), 4.50 (1H, d, J = 10.1 Hz, 
NH); 
13C NMR (100MHz, CDCl3) δC 17.5 (CH3, 4-C), 18.5 (CH3,  5-C), 28.3 (CH3, 8-C), 
30.3 (CH, 3-C), 43.8 (CH2, 1-C), 79.0 (C, 7-C), 156.5 (C, 6-C). 
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(S)-1-formylamino-2-tert-butyl  carbamate-3-methyl  butane  (S)-88:  Crude  (S)-87 
was dissolved in ethyl formate (50 mL) and stirred at reflux for 24 h after which the 
solvent was removed to afford (S)-88 as an off white solid: 
1H NMR (400 MHz, 
CDCl3) δH 0.88 (3H, d, J3-H,4-H = 7.6 Hz, 4-H), 0.89 (3H, d, J3-H,5-H = 7.1 Hz, 5-H), 1.37 
(9H, s, 8-H), 1.71 (1H, m, 3-H), 3.29 (2H, m, 1-H), 3.48 (1H, m, 2-H), 4.57 (1H, d, J = 
8.6 Hz, NH), 8.11 (1H, s, 9-H).  
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(S)-N-[2-[3-(3,5-Bis-trifluoromethyl-phenyl)-thioureido]-3-methyl-butyl]-
formamide  (S)-90:    Reaction  performed  on  3.2  mmol  scale  utilising  the  same 
procedure  for  the  preparation  of  (S)-65.    3,5-Bis(trifluoromethyl)phenyl 
isothiocyanate (0.5 mL, 3.3 mmol) was substituted for phenyl isothiocyanate.  (S)-
90 was purified on a column of silica gel using a Petrol – EtOAc mixture (1:2). The 
product was then recrystallised from EtOAc/Hexane but was still impure; 
1H NMR 
(400 MHz, CDCl3) δH 0.96 (6H, m, 4-H, 5-H), 1.67 (1H, m, 3-H), 3.15 (1H, m), 3.34 – 
3.59 (2H, m), 4.72 (1H, bs, NH), 6.27 (1H, bs, NH), 6.61 (1H, bs, NH), 7.56 (2H, s, 9-H 
and 13-H), 8.05 (1H, s, 11-H), 8.16 (1H, s, 6-H). P a g e  | 91 
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(S)-(-)-1-(3,5-dimethylphenylcarbamoyl)-2-methylpropyldiphenyl  phosphoramide 
(S)-(-)-91:  (S)-tert-butyl-1-(3,5-dimethylphenylcarbamoyl)-2-
methylpropylcarbamate (S)-100 (1.21 g, 3.7 mmol) was dissolved in a TFA/DCM 
(1:2) mixture and stirred at room temperature for 1h.  To the mixture was added 
saturated NaHCO3 until pH = 7 and the resulting mixture was then extracted with 
CH2Cl2  (3  x  25  mL).    The  organic  layer  was  dried  over  MgSO4  and  the  solvent 
removed under reduced pressure.  The residue was dissolved in CH2Cl2 (25 mL) and 
diphenylphosphinic acid chloride (0.73 mL, 3.8 mmol) and triethylamine (1.03 mL, 
7.4  mmol)  were  added.    The  mixture  was  allowed  to  stir  at  room temperature 
overnight after which the solvent was removed.  The residue was then dissolved in 
EtOAc (10 mL) and washed with sat. NaHCO3 solution (10 mL), 1M HCl (10 mL) and 
brine (10 mL).  The organic phase was dried over MgSO4 and the solvent removed 
under reduced pressure.  The residue was then recrystallised from ethanol to afford 
(S)-(-)-91 as an off white solid 80%; mp 184 – 187 
oC [α]D = -158.4
 (c = 1.0, CHCl3);
 1H 
NMR (400MHz, CDCl3) δH 0.80 (3H, d, J3-H,4-H = 6.4 Hz, 4-H), 0.98 (3H, d, J3-H,5-H = 6.4 
Hz, 5-H), 2.11 (1H, m, 3-H), 2.14 (6H, s, 18-H), 3.98 (2H, m, 2-H), 6.65 (1H, s, 1-NH), 
6.93 – 7.36 (8H, m), 7.47 (2H, m), 8.89 (1H, s, 2-NH); 
13C NMR (100 MHz, CDCl3) δC 
17.9 (CH3, 4-C), 18.5 (CH3, 5-C), 21.4 (CH3, 18-C), 29.7 (CH, 3-C), 61.9 (CH, 2-C), 117.7 
(CH), 121.6 (CH), 121.8 (CH), 126.0 (CH), 126.4 (CH), 128.4 (C), 129.7 (CH), 129.9 
(CH), 130.1 (CH), 130.2 (CH), 137.8 (C), 138.5 (C), 147.7 (C), 170.3 (1-C); EI MS m/z 
(%)  HRMS 450.1708 (C25H27O4N2P requires 450.1708); Anal. Calcd. for C25H29N2O2P: 
C 71.87 H 7.19 N 6.45. Found C 71.61 H 6.86 N 6.43. 
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(S)-94: Reaction carried out on 3.92 mmol scale utilising the same procedure as for 
(S)-91.  (S)-94 was isolated by crystallisation form EtOH in 33% yield: mp 218 – 221 
oC; 
1H NMR (400MHz, CDCl3) δH 0.80 (3H, d, J3-H,4-H = 6.4 Hz, 4-H), 0.98 (3H, d, J3-H,5-H 
= 6.4 Hz, 5-H), 2.06 (1H, m, 3-H), 2.14 (6H, s, 16-H), 4.01 (1H, m, 2-H), 6.65 (1H, s, 1-
NH), 7.13 (2H, s, Ar-H), 7.35 (4H, m, Ar-H), 7.48 (2H, m, Ar-H), 8.89 (1H, s, 2-NH); 
13C 
NMR (100 MHz, CDCl3) δC 17.9 (CH3, 4-C), 18.5 (CH3, 5-C), 21.4 (CH3, 16-C), 29.7 (CH, 
3-C), 61.9 (CH, 2-C), 117.7 (CH), 121.6 (CH), 121.8 (CH), 126.0 (CH), 126.4 (CH), 
128.4 (C), 129.7 (CH), 129.9 (CH), 130.1 (CH), 130.2 (CH), 137.8 (C), 138.5 (C), 147.7 
(C), 170.3 (C, 1-C); MS EI m/z (%) 450.1 (19, M), 302.1 (100); HRMS (EI) 450.1708 
(C25H27N2O4P requires 450.1705). 
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(S)-N-(diphenylphosphine oxide)-valinol (S)-95: To a solution of valinol (1.0 g, 9.69 
mmol) in CH2Cl2 (20 mL) at 0 
oC was added triethylamine (3.23 mL, 23.2 mmol) and 
diphenylphosphinic acid chloride (2.22 mL, 11.69 mmol).  The mixture was then 
allowed to reach room temperature and stirred for 16 h.  The reaction mixture was 
then diluted with 1M HCl until neutral and extracted with CH2Cl2 (3 x 25 mL).  The 
organic  layer  was  dried  over  MgSO4,  filtered  and  the  solvent  removed  under P a g e  | 93 
 
reduced pressure.  The residue was purified on a column of silica gel with a Pet 
Ether-EtOAc  mixture  (4:1)  and  then  recrystallised  from  hexane/ethyl  acetate  to 
afford  a white solid (67%) which was identified as a mixture of cis/trans isomers of 
(S)-95; mp 84 – 86 
oC and 95 – 101 
oC; 
1H NMR (400MHz, CDCl3) δH 0.62 (d, J = 6.8 
Hz, 4-H), 0.81 (d, J = 6.8 Hz, 5-H), 0.87 (d, J = 6.8 Hz, 4-H), 0.95 (d, J = 6.8 Hz, 5-H), 
1.45 (m, ), 1.91 (m, ), 2.40 (m, ), 2.99 (m, ), 7.42 (6H, m), 7.87 (4H, m).  
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(R,S)-(+)-1,1’-Binaphthyl-2,2’diyl-N-(α-(S)-methylbenzyl)  phosphoramidate  (R,S)-
(+)-96: Prepared by modification of the protocol developed by Hu
[86].  The crude 
phosphoric acid chloride 101 was dissolved in CH2Cl2 (10 mL) and cooled in a salt-ice 
bath.  A solution of (S)-methylbenzylamine (1.4 mL, 10.5 mmol) and triethylamine 
(1.67 mL, 12.08 mmol) in CH2Cl2 (10 mL) was added.  The mixture was left to stir for 
30 minutes then allowed to reach room temperature and left to stir for 36 hours.  
The solution was then washed with 0.5M HCl (20 mL) and brine (25 mL), dried over 
MgSO4 and the solvent removed under reduced pressure.  The crude mixture (70%) 
of diastereomers was dissolved in refluxing ethanol (50 mL) and left to recrystallise 
over  48  hours  to  afford  (R,S)-(+)-96  as  yellow  crystals;  [α]D  =  +316
o; 
1H  NMR 
(400MHz, CDCl3) δH 1.48 (3H, d, J = 6.8 Hz, ), 3.31 (1H, t, J = 10.4 Hz, NH), 4.42 (1H, 
m, ), 6.69 – 7.50 (12H, m), 7.53 (1H, d, J = 4.8 Hz), 7.77 (1H, d, J = 9.2 Hz), 7.85 (2H, 
dd, J = 2.8 Hz, J = 8.4 Hz), 7.93 (1H, d, J = 8.8 Hz); 
31P NMR (160 MHz, CDCl3) δP 12.30 
in agreement with the literature.
[86] 
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(S)-(-)-tert-butyl-1-(3,5-dimethylphenylcarbamoyl)-2-methylpropylcarbamate      
(S)-(-)-100: Methyl chloroformate (0.55 mL, 7.15 mmol) was added dropwise to a 
stirred solution of (S)-70 (1.40 g, 6.05 mmol) and triethylamine (1.0 mL, 7.15 mmol) 
in anhydrous THF (30 mL) at 0 
oC under an argon atmosphere and the mixture was 
stirred  at  that  temperature  for  2  h.    The  precipitate  was  removed  by  suction 
filtration and the filtrate was added dropwise to a solution of the corresponding 
amine (8.5 mmol) and triethylamine (1.0 mL, 7.15 mmol) in anhydrous THF (30 mL) 
at 0 
oC.  The mixture was allowed to stir at room temperature overnight under an 
argon atmosphere and the solvent was then removed under reduced pressure.  The 
residue was purified using column chromatography on silica gel with a petroleum 
ether-ethyl  acetate  mixture  (4:1)  to  afford  (S)-tert-butyl-1-(3,5-
dimethylphenylcarbamoyl)-2-methylpropylcarbamate  (S)-(-)-100  as  a  white  solid; 
mp 137 – 140 
oC; [α]D -12.0 (c = 0.5, CHCl3); 
1H NMR (400MHz, CDCl3) δH 0.75 (6H, d, 
J = 6.8 Hz, 4-H, 5-H), 1.37 (9H, s, 8-H), 2.20 (6H, s, 15-H), 2.24 (1H, m, 3-H), 4.04 (2H, 
m, 2-H), 5.36 (1H, d, J = 8.4 Hz, 2-NH), 6.59 (1H, s, 12-H), 7.18 (2H, s, 10-H, 14-H), 
8.46 (1H, bs, 1-NH); 
13C NMR (100 MHz, CDCl3) δC 17.6 (CH3, 4-C), 18.3 (CH3, 5-C), 
20.2 (CH3, 13-C), 27.3 (CH3, 8-C), 30.2 (CH, 3-C), 59.9 (CH, 2-C), 78.9 (C, 7-C), 116.7 
(CH, 10-C), 124.7 (CH, 12-C), 136.6 (C, 9-C), 137.3 (C, 11-C), 155.5 (C, 6-C), 169.9 (C, 
1-C); MS EI m/z (%) 320.1 (100, M), 121.1 (100), 72.1 (88), 57.1 (73); HRMS (EI) 
320.2100 (C18H28N2O3 requires 320.2099); Anal. Calcd. for C18H28N2O3: C 66.79 H 
7.56 N 10.16. Found C 66.49 H 8.78 N 9.03. 
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Biphenyl-2,2’-chlorophosphate  101:        2,2’-biphenol  (2,00  g,  10.7  mmol)  was 
dissolved in toluene (25 mL) and cooled to 0 
oC.  To the reaction mixture, a solution 
of POCl3 (2.40 mL, 16.0 mmol) and Et3N (4.5 mL, 32.0 mmol) was added slowly.  The 
reaction mixture was then allowed to warm to room temperature and stirred for 36 
h after which the solid residue was removed via vacuum filtration and the solution 
concentrated in vacuo to afford 101 as a yellow oil 95%: 
1H NMR (400MHz, CDCl3) 
δH 
13C NMR (100 MHz, CDCl3) δC 120.7 (CH), 126.7 (CH), 127.3 (6-C), 129.4 (CH), 129.7 
(CH), 146.7 (1-C); 
31P NMR (160 MHz, CDCl3) δP 10.17; EI MS m/z (%) 266.0 (100, M), 
168.1  (76),  139.1  (24),  82.9  (48);  HRMS  (EI)  265.9900  (C12H8O3ClP  requires 
265.9902) in agreement with literature.
[87] 
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Phosphoric acid chloride 102: Prepared following the protocol developed by Hu
[86].  
Racemic Binol (3 g, 10.5 mmol) was slurried in CH2Cl2 (100 mL) and POCl3 (2.25 g, 
14.7 mmol) was added followed by slow addition with stirring of triethylamine (2.6 
g, 25.5 mmol) so as to maintain gentle reflux.  After 1h the reaction mixture was 
washed with water (25 mL) and evaporated to afford the crude acid chloride 102 
which was carried on without purification. 
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(R),(R)-105: Diamine (-)-104 (50 mg, 0.24 mmol) was dissolved in CH2Cl2 (2 mL) and 
diphenylphosphinic acid chloride (110 mg, 0.50 mmol) and triethylamine (0.14 mL, 
0.60 mmol) were added.  The mixture was allowed to stir at room temperature 
overnight after which the solvent was removed.  The residue was then dissolved in 
EtOAc (10 mL) and washed with sat. NaHCO3 solution (10 mL), 1M HCl (10 mL) and 
brine (10 mL).  The organic phase was dried over MgSO4 and the solvent removed 
under reduced pressure.  The residue was then recrystallised from toluene to afford 
(R),(R)-105 as an off white solid (72%): 
1H NMR (400MHz, CDCl3) δH 4.19 (2H, m, 1-
H), 5.81 (2H, m, NH), 6.77 (4H, m, Ar-H), 7.04 (6H, m, Ar-H), 7.15 (6H, m, Ar-H), 7.32 
(8H, m, Ar-H), 7.43 (2H, m, Ar-H), 7.58 (4H, m, Ar-H), 7.71 (4H, m, Ar-H); 
13C NMR 
(100 MHz, CDCl3) δC 61.7 (CH), 126.9 (CH), 127.4 (CH), 128.0 (CH), 128.1 (CH), 128.3 
(CH), 128.4 (CH), 128.5 (CH), 131.0 (C), 131.5 (CH), 131.6 (CH), 131.6 (CH), 131.8 (C), 
131.9 (C), 131.9 (CH), 133.0 (CH), 141.9 (C), 142.0 (C); MS FAB m/z (%) 613.1 (77, 
M+H),  396.1  (48),  306.1  (86),  201.5  (100),  107.7  (41);  HRMS  (FAB)  613.2174 
(C38H35N2O2P2 requires 613.2179). 
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(S)-(-)-N-Formyl-valinol: Valinol (4.64 g, 44.9 mmol) was dissolved in ethyl formate 
(20 mL) and allowed to reflux for 16h.  The solvent was removed in vacuo to afford 
N-Formyl-valinol as a yellow oil which was carried on without purification; [α]D -
32.9 (c = 1.0, CHCl3); 
1H NMR (400MHz, CDCl3) δH 0.90 (3H, d, J4-H,3-H = 6.8 Hz, 4-H), 
0.98 (3H, d, J5-H,3-H = 6.8 Hz, 5-H), 1.85 (1H, m, 3-H) 2.29 (1H, m, 2-H), 3.34 (1H, dd, 
J1α-H,1β-H, J1α-H,2-H = 10.4 Hz, 1α-H), 3.64 (1H, dd, J1α-H,1β-H = 6.4 Hz, J1β-H,2-H = 4.0 Hz, 1β-
H), 8.19 (1H, s, 6-H); 
13C NMR (100 MHz, CDCl3) δC 18.6 (CH, 4-C), 19.3 (CH, 5-C), 
29.3 (CH, 3-C), 55.9 (CH, 2-C), 63.3 (CH2, 1-C), 165.7 (C, 6-C); CI MS m/z (%) 132.2 
(100,  M+H),  114.2  (45),  104.2  (22);  HRMS  (CI)  132.1025  (C6H14NO2  requires 
132.1022); Anal. Calcd. for C7H15NO2: C 57.90 H 10.41N 9.65. Found: C 57.87 H 
10.36 N 9.47 in agreement with literature values.
[88] 
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(S)-(-)-2-(5-Phenyl-4,5-dihydro-thiazol-2-yl)-pyridine  (S)-(-)-119:    To  a  solution  of 
(S)-130 (1.29 g, 4.99 mmol) in THF (15 mL) at 0
oC was added mesyl chloride (0.57 
mL, 7.01 mmol) and triethylamine (2.15 mL, 14.3 mmol).  The reaction was then 
allowed to stir at room temperature for 48h.  Water (10 mL) was then added and 
the mixture extracted with DCM (3 x 20 mL).  The organic layer was dried over 
MgSO4 and the solvent removed in vacuo.  The crude solid was then purified on a 
column of silica gel (20 g) with a Pet Ether-EtOAc mixture (1:1) to afford an off 
white solid which was recrystallised from EtOH to afford 2-(5-Phenyl-4,5-dihydro-
thiazol-2-yl)-pyridine (S)-(-)-119 as a white crystalline solid (0.98 g, 82%); mp 105 – 
106 
oC;
 [α]D –77.50 (c 1.0, CHCl3);
 1H NMR (400 MHz, CDCl3) δH 4.60 (1H, dd, J8α-H,8β-H 
= 16.4 Hz, J9-H,8α-H = 5.8 Hz, 8α-H), 4.82 (1H, dd, J8α-H,8β-H = 16.4 Hz, J9-H,β-H = 9.1 Hz, 
8β-H), 4.99 (1H, dd, J9-H,8α-H = 5.8 Hz, J9-H,β-H = 9.1 Hz, 9-H), 7.17 – 7.33 (6H, m), 7.73 
(1H, dt, J = 7.8 Hz, J = 1.8 Hz), 8.05 (1H, dt, J = 7.8 Hz, J = 1.0 Hz), 8.60 (1H, ddd, J = 
4.8 Hz, J = 1.0 Hz, J = 0.8 Hz); 
13C NMR (100 MHz, CDCl3) δC 53.5 (CH, 9-C), 73.9 (CH2, 
8-C), 121.6 (CH), 125.5 (CH), 127.2 (CH), 127.7 (CH), 128.9 (CH), 136.6 (CH), 142.2 
(C, 2-C), 149.4 (CH), 151.2 (C, 9-C), 170.2 (C, 7-C); MS EI+ m/z (%) 240.1 (M+, 100), 
118.0 (49), 78.0 (74), 51.0 (20); HRMS (EI) 240.0721 (C14H12N2S requires 240.0718). 
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(S)-(-)-1-(5-Phenyl-4,5-dihydro-thiazol-2-yl) isoquinoline (S)-(-)-120:  
Method A: (R)-(-)-N-(2-hydroxy-2-phenylethyl)isoquinoline-1-carboxyamide (R)-136 
(100 mg, 0.34 mmol) and Lawesson’s reagent (165 mg, 0.41 mmol) were dissolved 
in HMPA (2.0 mL) and heated at 120 
oC overnight.  The reaction mixture was then 
allowed to cool down and acidified to pH = 3 with 2M HCl and the precipitate 
filtered off.  The filtrate was then extracted with CH2Cl2 (3 x 30 mL) and the organic 
layer washed with water (3 x 15 ml).  The organic layer was dried over MgSO4, 
filtered and the solvent removed.  The crude residue was then purified on a column 
of silica gel with a Petrol – EtOAc mixture (5:1) to afford (S)-(-)-120 as a brown oil (7 
mg, 7%). 
 
Method B: (R)-138 (253 mg, 0.71 mmol) and Lawesson’s reagent (344 mg, 0.85 
mmol)  were  dissolved  in  toluene  (20  mL)  and  heated  at  85 
oC  overnight.    The 
reaction mixture was then allowed to cool down and acidified to pH = 3 with 2M 
HCl and the precipitate filtered off.  The filtrate was then extracted with CH2Cl2 (3 x 
30 mL) and the organic layer washed with water (3 x 15 ml).  The organic layer was 
then dried over MgSO4, filtered and the solvent removed.  The crude residue was 
then purified on a column of silica gel with a Pet Ether – EtOAc mixture (5:1) to 
afford  (S)-(-)-120    as  a yellow  oil  (74%):  [α]D  =  -22.9
o (c  =  1.0,  CHCl3);
  1H  NMR 
(400MHz, CDCl3) δH 4.78 (1H, dd, J = 4.3, 15.2 Hz, 2-H), 4.83 – 4.89 (1H, m, 1α-H), 
5.02 – 5.06 (1H, m, 1β-H), 7.17 (m, 1H), 7.21 – 7.25 (m, 2H), 7.33 – 7.35 (m, 2H), 
7.59 – 7.66 (m, 3H), 7.89  - 7.97 (m, 1H), 8.52 (d, J = 5.6 Hz, 1H), 9.42 (dd, J = 1.5, 7.8 
Hz, 1H); 
13C NMR (100 MHz, CDCl3) δC 52.2 (CH, C-2), 75.2 (CH2, C-1), 123.2 (CH), 
126.4 (C-3), 127.0 (CH), 127.2 (CH), 127.5 (CH), 127.6 (CH), 128.9 (CH), 130.4 (CH), 
136.9 (C-14), 141.5 (CH), 142.4 (CH), 149.2 (C-9), 168.1 (C-8), 170.9 (C-7); MS EI m/z P a g e  | 100 
 
(%) 290.1 (M+, 100), 186.0 (44), 128.0 (92), 91.0 (28); HRMS EI 290.0878 (C18H14N2S 
requires 290.0879). 
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(S)-(+)-2-(5-Phenyl-4,5-dihydro-thiazol-2-yl)-quinoline (S)-(+)-122: Reaction carried 
out on a 3.66 mmol scale utilising the same procedure as for (S)-(-)-119.  After 
recrystallisation from EtOH (S)-(+)-122 was isolated as black crystals (77%); mp 118 
– 120 
oC; [α]D +126.6 (CHCl3, c = 0.25); 
1H NMR (400MHz, CDCl3) δH 4.66 (1H, dd, 
J12α-13 = 6.0 Hz, J12α-12β = 16.4 Hz, 12α-H), 4.87 (1H, dd, J12β-13 = 9.2 Hz, J12α-12β = 16.8 
Hz, 12β-H), 5.02 (1H, dd, J12α-13 = 6.0 Hz, J12β-13 = 9.2 Hz, 13-H), 7.20 (1H, m, Ar-H), 
7.25 (2H, m, Ar-H), 7.32 (2H, m, Ar-H), 7.53 (1H, m, Ar-H), 7.67 (1H, m, Ar-H), 7.78 
(1H, m, Ar-H), 8.15 (3H, m, Ar-H); 
13C NMR (100 MHz, CDCl3) δC 53.4 (CH, 12-C), 74.1 
(CH2, 13-C), 118.7 (CH), 127.3 (CH), 127.6, (CH), 127.7 (CH), 127.9 (CH), 128.9 (CH), 
128.9 (C), 130.0 (CH), 130.1 (CH), 136.6 (CH), 142.3 (C), 147.6 (C), 151.1 (C), 171.0 
(C);  MS  CI  m/z  (%)  291.2  (100,  M+H);  HRMS  (CI)  291.0956  (C18H15N2S  requires 
291.0953). 
 
 
O
NH2 HO
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(R)-(-)-2-Hydroxy-2-phenyl  acetamide  (R)-(-)-127:  Prepared  according  to  the 
protocol of Brunner
[78], acetyl chloride (4.4 mL) was added to a solution of (R)-
mandelic acid (8.4 g, 54.6 mmol) in methanol (200 mL) at 0 
oC.  The reaction was 
then allowed to reach room temperature and stirred overnight.  The solvent was 
then removed and the solid residue dissolved in a mixture of methanol (150 mL) 
and  aqueous  ammonium  hydroxide  (28%,  445  mL)  and  stored  in  the  fridge P a g e  | 101 
 
overnight.  The solvent was then removed and the solid residue recrystallised from 
toluene to give pure amide (90%) as a white solid: 
1H NMR (400 MHz, CDCl3) δH 2.19 
(1H, bs, OH), 5.11 (1H, s, 2-H), 5.59 (1H, bs, NH), 6.02 (1H, bs, NH), 7.36-7.47 (5H, m, 
Ar) in agreement with the literature.
[78] 
 
 
NH2 HO
Ph
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(R)-(-)-2amino-1-phenyl  ethanol  (R)-(-)-124:  Prepared  according  to  the  protocol 
developed by Brunner
[78], to a suspension of (R)-(-)-2-Hydroxy-2-phenyl-acetamide 
(R)-(-)-127 (1.88 g, 12.4 mmol) in THF (100 mL) at 0 
oC was slowly added LiAlH4 (1.2 
g, 31.03 mmol).  The reaction was allowed to stir at this temperature for 2 h and 
was  then  heated  overnight  at  70 
oC.    The  mixture  was  then  cooled  to  0 
oC, 
NaSO4.10H2O was added to remove excess LiAlH4 and the mixture was then filtered 
through Celite.  The solvent was then removed in vacuo to afford (R)-(-)-2-amino-1-
phenyl ethanol as a yellow oil (84%); [α]D -26.6 (c = 0.5, CHCl3);  
1H NMR (400 MHz, 
CDCl3) δH 1.78 (bs, 3H), 2.74 (1H, dd, J2α,2β = 12.8 Hz, J1,2α = 7.8 Hz, 2α-H), 2.93 (1H, 
dd, J2α,2β = 12.8 Hz, J1,2β  = 4.0 Hz, 2β-H), 4.56 (1H, dd, J1,2α = 7.8 Hz, J1,2β  = 4.0 Hz, 1-
H), 7.19-7.36 (m, 5H); 
13C NMR (100 MHz, CDCl3) δC 49.2 (CH2, 2-C), 68.0 (CH, 1-C), 
126.0 (CH), 127.7 (CH), 128.5 (CH), 142.6 (C); MS CI m/z (%) 138.2 (100, M+H), 120.2 
(70);  HRMS  (CI)  138.0919  (C8H12NO  requires  138.0918)  in  accordance  with  the 
literature.
[78] 
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Methyl  2-pyridylthiocarboxylate  129:  Prepared  according  to  the  protocol 
developed by Metzner et al.
[89]  To a mixture of 2-picolylchloride hydrochloride (2.0 
g, 12.2 mmol) in DCM (5.0 mL) and H2O (5.0 mL), was added a saturated aqueous 
solution of NaHCO3 until neutralisation.  The mixture was then extracted with DCM 
and the organic layer dried over MgSO4.  The solvent was removed to afford the 
free amine.  Sulfur (1.18 mg, 34.5 mmol), DMF (6.0 mL) and triethylamine (5.0 mL, 
34.5 mmol) were added to the free amine and the mixture was allowed to stir for 
18h.  The reaction mixture was then cooled to 0 
oC and methyl iodide (6.8 mL, 109 
mmol)  was  added  dropwise.    The  reaction  mixture  was  then  stirred  at  room 
temperature for 20 minutes after which ether was added until the mixture was 
homogeneous.  The reation mixture was then washed with brine (20 mL) and the 
red aqueous layer extrated with ether until it became yellow.  The organic layer was 
then dried over MgSO4 and the solvent removed in vacuo.  The residue was then 
purified on a column of silica gel (25 g) with a Pet Ether-EtOAc mixture (1:1) to 
afford methyl 2-pyridylthiocarboxylate as deep red crystals (1.05 g, 51%); 
1H NMR 
(400 MHz, CDCl3) δH 2.68 (3H, s, 8-H), 7.41 (1H, ddd, J =  7.6 Hz, J = 4.8 Hz, J = 1.2 
Hz), 7.72 (1H, dt, J = 7.8 Hz, J = 1.8 Hz), 8.26 (1H, dt, J = 8.1 Hz, J = 1.0 Hz), 8.56 (1H, 
ddd, J = 1.0 Hz, J = 4.8 Hz, J = 1.8 Hz) in agreement with literature.
[89] 
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N-((S)-2-hydroxy-2-phenylethyl)pyridine-2-carbothioamide  (S)-130:  Prepared  by 
modification of the protocol developed by Masson
[90].  To a solution of thioester P a g e  | 103 
 
129 (1.05 g, 6.4 mmol) in THF was added amino alcohol (1.20 g, 8.5 mmol) and 
triethylamine (1.12 mL, 8.5 mmol).  The reaction mixture was allowed to stir at 
room temperature for 18h after which the solvent was removed in vacuo.  The 
residue was then purified on a column of silica gel (35 g) wlth a Pet Ether-EtOAc 
mixture  (1:1)  to  afford  Pyridine-2-carbothioic  acid  (2-hydroxy-2-phenyl-ethyl)-
amide as a colourless oil (1.289 g, 78%); 
1H NMR (400 MHz, CDCl3) δH 3.82 (1H, ddd, 
J = 10.1 Hz, J = 8.8 Hz, J = 4.8 Hz, 8α-H) 4.35 (1H, ddd, J = 13.9 Hz, J = 7.1 Hz, J = 3.3 
Hz, 8β-H) 5.11 (1H, dd, J = 8.8 Hz, J = 3.3 Hz, 9-H), 7.24 – 7.42 (6H, m), 7.77 (1H, dt, J 
= 7.8 Hz, J = 1.7 Hz), 8.42 (1H, ddd, J = 4.8 Hz, J = 1.8 Hz, J = 1.0 Hz), 8.63 (1H, dt, 8.1 
Hz, J = 1.0 Hz), 10.50 (1H, bs, N-H). 
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Methyl 2-quinolinylldithiocarboxylate 132: Reaction carried out on a 4.67 mmol 
scale utilising the same procedure as for 129
[89].  The residue was purified on a 
column of silica gel (25 g) with a Pet Ether-EtOAc mixture (1:1) to afford 132 as a 
deep pink solid (1.02 g, 100%); mp 98 – 101 
oC; 
1H NMR (400 MHz, CDCl3) δH 2.73 
(3H, s, 12-H), 7.57 (1H, ddd, J = 1.3 Hz, J = 7.1 Hz, J = 8.1 Hz), 7.72 (1H, ddd, J = 1.3 
Hz, J = 6.8 Hz, J = 8.3 Hz), 7.79 (1H, dd, J = 1.0 Hz, J = 8.3 Hz), 8.16 (2H, dd, J = 3.0 Hz, 
J = 8.6 Hz), 8.37 (1H, d, J = 8.6 Hz); 
13C NMR (100 MHz, CDCl3) δC 20.2 (CH3, 12-C), 
119.5 (C, 5-C), 127.6 (CH), 128.4 (CH), 129.5 (C, 10-C), 130.4 (CH), 130.6 (CH), 136.6 
(CH), 146.3 (C, 2-C), 228.7 (C, 11-C); MS FAB m/z (%) 220.3 (M+H, 100), 172.8 (69), 
154.9  (40),  137.2  (46),  129.3  (38);  HRMS  (FAB)  220.0255  (C11H10NS2  requires 
220.0252). 
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(R)-Quinoline-2-carbothioic  acid  (2-hydroxy-2-phenyl-ethyl)-amide  (R)-133: 
Reaction  carried  out  on  a  4.67  mmol  scale  utilising  the  same  procedure  as  for 
130
[90].  133 was isolated as a yellow/orange oil (1.13 g, 78%);  
1H NMR (400MHz, 
CDCl3) δH 3.91 (1H, ddd, J = 4.8 Hz, J = 8.6 Hz, J12α-H,NH = 13.6 Hz, 12α-H), 4.41 (1H, 
ddd, J = 3.5 Hz, J = 7.1 Hz, J12β-H,NH = 13.9 Hz, 12β-H), 5.18 (1H, dd, J = 3.5 Hz, J = 8.8 
Hz, 13-H), 7.27 – 7.30 (1H, m), 7.34 – 7.38 (2H, m), 7.43 – 7.48 (2H, m), 7.56 (1H, 
ddd, J = 1.3 Hz, J = 7.1 Hz, J = 8.1 Hz), 7.70 (1H, ddd, J = 1.3 Hz, J = 6.8 Hz, J = 8.3 Hz), 
7.80 (1H, d, J = 7.8 Hz), 8.02 (1H, d, J = 8.6 Hz), 8.21 (1H, d, J = 8.6 Hz), 8.77 (1H, d, J 
= 8.6 Hz), 10.70 (1H, bs, NH); 
13C NMR (100 MHz, CDCl3) δC 52.9 (CH2, 12-C), 72.6 
(CH, 13-C), 121.4 (CH), 125.9 (CH), 127.7 (CH), 128.1 (CH), 128.3 (CH), 128.8 (CH), 
129.2 (C, 14-C), 129.9 (CH), 130.4 (CH), 137.0 (CH), 141.5 (C, 5-C), 145.5 (C, 10-C), 
150.2 (C, 2-C), 192.1 (C, 11-C).  
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(R)-(-)-N-(2-hydroxy-2-phenylethyl)isoquinoline-1-carboxyamide  (R)-(-)-136: 
Methylchloroformate (0.68 mL, 8.79 mmol) was added dropwise to a solution of 1-
isoquinoline carboxylic acid, 135 (1.17 g, 7.33 mmol) and triethylamine (1.23 mL, 
8.79 mmol) in THF (30 mL) at 0 
oC and stirred at that temperature for 1 h.  The 
precipitate was removed by filtration in vacuo and the filtrate added to a solution of 
(R)-2-amino-1-phenyl-ethanol, 124  , (1.19 g, 8.79 mmol) and triethylamine (1.23 P a g e  | 105 
 
mL, 8.79 mmol) in THF (30 mL) at 0 
oC and the mixture allowed to reach room 
temperature and stirred overnight.  The solvent was then removed and the residue 
purified on a column of silica gel with a Petrol – EtOAc mixture (1:1) to afford (R)-(-
)-136 as a white solid (89%); [α]D -78.6 (c = 0.5, CHCl3); 
1H NMR (400 MHz, CDCl3) δH 
3.48 (1H, ddd, J1α,1β = 13.9 Hz, J1α,2 = 8.6 Hz, J1α,NH = 5.3 Hz, 1α-H), 3.85 (1H, ddd, 
J1α,1β = 13.9 Hz, J1β,NH = 7.1 Hz, , J1β,2 = 3.3 Hz, 1β-H), 5.08 (1H, dd, J1α,2 = 8.6 Hz, J1β,2 = 
3.3 Hz, 2-H), 7.15-7.26 (3H, m), 7.37 (2H, d, J = 7.1 Hz,), 7.49-7.57 (2H, m), 7.59 (d, J 
= 5.3 Hz, 2H), 7.70 (1H, d, J = 7.6 Hz,), 8.17 (1H, d, J = 5.6 Hz,), 8.67 (1H, t, J = 5.8 Hz, 
18-H), 9.30 (1H, d, J = 8.6 Hz, 12-H); 
13C NMR (100 MHz, CDCl3) δC 47.9 (CH, 1-C), 
74.2 (CH2, 2-C), 124.6 (CH), 125.9 (CH), 126.9 (CH), 127.1 (C, 3-C), 127.7 (CH), 127.9 
(CH), 128.6 (CH), 128.8 (CH), 130.6 (CH), 137.4 (C, 11-C), 140.28 (CH), 141.9 (C, 16-
C), 147.9 (C, 10-C), 167.5 (C, 9-C) CI MS m/z (%) 293 ([M+H]
+, 100), 275 (15), 186 (7), 
173 (5), 123 (4), 107 (5); HRMS (CI) 293.1288 (C18H17N2O2 requires 293.1290).  
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(R)-(-)-N-(2-tert-butyldimethylsilanoxy-2-phenylethyl)isoquinoline-1-
carboxyamide  (R)-(-)-138:    (R)-136  (500  mg,  1.71  mmol),  tert-butyldimethylsilyl 
chloride (309 mg, 2.05 mmol) and imidazole (291 mg, 4.28 mmol) were dissolved in 
DMF (5 mL) and allowed to stir at room temperature overnight.  The mixture was 
then diluted with aqueous NH4Cl and extracted with CH2Cl2.  The organic phase was 
washed with brine (3 x 25 mL) dried over MgSO4 and the solvent removed under 
reduced pressure to afford (R)-(-)-138 as a colourless oil (63%); [α]D -23.70 (c = 1.00, 
CHCl3); 
 1H NMR (400 MHz, CDCl3) δH 0.01 (6H, s, 19-H, 20-H), 0.82 (9H, s, 22-H), 
3.36 (1H, ddd, J = 13.89 Hz, J = 8.4 Hz, J = 4.8 Hz, 1α-H), 3.90 (1H, ddd, J = 13.6 Hz, J 
= 8.0 Hz, J = 4.0 Hz, 1β-H), 4.90 (1H, dd, J = 8.4 Hz, J = 4.0 Hz, 2-H), 7.31 – 7.41 (5H, 
m), 7.65 – 7.84 (3H, m), 8.44 (1H, d, J = 5.6 Hz), 8.62 (1H, bs), 9.61 (1H, d, J = 5.2 Hz); P a g e  | 106 
 
13C NMR (100 MHz, CDCl3) δC -4.6  (CH3, C-19), -3.6 (CH3, C-20), 18.2 (C-21), 25.7 
(CH3, C-22), 47.9 (CH2, C-1), 74.0 (CH, C-2); MS EI m/z (%) 406.14 (M+, 5), 349.11 
(42), 221.1 (100), 185.1 (35), 128.0 (54), 73.0 (60); HRMS 406.2077 (C24H30O2N2Si 
requires 406.2076); Anal. Calcd. for C24H30N2O2Si: C 70.90 H 7.44 N 6.89. Found C 
70.81 H 7.44 N 6.69.  
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N-((R)-2-hydroxy-2-phenylethyl)isoquinoline-3-carboxamide  (R)-140:    Reaction 
carried out on 2.89 mmol scale utilising the same procedure for (R)-136.  (R)-140 
was purified on a column of silica gel with a Petrol – EtOAc mixture (1:1) to afford 
the product as a white solid (43%); mp 104 – 105 
oC; 
1H NMR (400 MHz, CDCl3) δH 
3.86 (1H, t, J = 10.6 Hz, 1α-H), 4.21 (1H, dd, J1β,2 = 5.6 Hz, J1α,1β = 10.6 Hz, 1β-H), 5.05 
(1H, dd, J1β,2 = 5.6 Hz, J1α,2 = 10.4 Hz, 2-H), 7.23 – 7.38 (6H, m), 7.59 (1H, dt, J = 1.26 
Hz, J = 6.8 Hz), 7.66 (1H, dt, J = 1.3 Hz, J = 6.8 Hz), 7.84 (1H, d, J = 8.3 Hz), 7.90 (1H, 
d, J = 8.3 Hz), 8.22 (1H, s), 9.07 (1H, s); 
13C NMR (100 MHz, CDCl3) δC 55.7 (CH2, 1-C), 
76.8 (CH, 2-C), 121.7 (CH), 126.4 (CH), 126.6 (CH), 127.5 (CH), 127.7 (CH), 128.5 
(CH), 128.5 (CH), 128.6 (CH), 128.9 (C), 130.9 (CH), 135.9 (C), 137.7 (C), 148.4 (C), 
150.8 (CH), 164.7 (9-C); CI+ MS m/z (%) 293.3 (M+H, 100), 275.3 (15), 107.2 (72), 
85.2 (88); HRMS (CI+) 293.1290 (C18H17N2O2 requires 293.1288). 
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N-((R)-2-tert butyldimethylsilyloxy-2-phenylethyl)isoquinoline-3-carboxamide (R)-
141: Reaction carried out on 1.26 mmol scale utilising the same procedure for (R)-
138.  (R)-141 was isolated as a colourless oil (59%); 
1H NMR (400 MHz, CDCl3) δH 
0.01 (6H, s, 19-H, 20-H), 0.84 (9H, s, 22-H), 3.84 (1H, t, J = 10.6 Hz, 1α-H), 4.20 (1H, 
dd, J1α,1β = 10.8 Hz, J1β,2 = 5.3 Hz, 1β-H), 5.04 (1H, dd, J1α,2 = 10.4 Hz, J1β,2 = 5.6 Hz, 2-
H), 7.22 – 7.37 (6H, m), 7.58 (1H, dt, J = 1.26 Hz, J = 6.8 Hz), 7.65 (1H, dt, J = 1.3 Hz, J 
= 6.8 Hz), 7.83 (1H, d, J = 8.3 Hz), 7.87 (1H, d, J = 8.3 Hz), 8.20 (1H, s), 9.06 (1H, s); CI 
MS  m/z  (%)  423.3  (100,  M+H),  155.2  (54);  HRMS  (CI)  423.1926  (C24H31N2OSiS 
requires 423.1923). 
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Chloromethyl-3-isoquinoline 143:  Prepared according to a literature procedure
[91].  
Methyl-3-isoquinoline (250 mg, 1.75 mmol) and trichloroisocyanuric acid (162 mg, 
0.7 mmol) were refluxed in CHCl3 (10 mL) overnight, the mixture was then cooled to 
room temperature and filtered.  The filtrate was diluted with CH2Cl2 (20 mL) and 
washed with NaOH (2M, 2 x 15 mL) and brine (2 x 15 mL).  The organic phase was 
then dried over MgSO4, filtered and evaporated to afford 143 as a colourless oil 
(311 mg, 100%); 
1H NMR (400 MHz, CDCl3) δH 5.01 (2H, s, 11-H), 7.65 (1H, ddd, J = 
1.3 Hz, J = 7.1 Hz, J = 8.1 Hz), 7.78 (1H, m), 7.94 (1H, m), 8.19 (1H, m), 9.11 (1H, d, J 
= 6.6 Hz) in agreement with literature values.
[91] 
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Methyl-3-isoquinolinylthiocarboxylate  144:  Prepared  by  modification  of  the 
protocol of Metzner et al
[89]  To a solution of 143 (311 mg, 1.75 mmol) in DMF (6.0 
mL) was added sulfur (169 mg, 4.95 mmol) and triethylamine (0.69 mL, 4.95 mmol) 
were added and the mixture was allowed to stir for 18h.  The reaction mixture was 
then cooled to 0
oC and methyl iodide (0.97 mL, 15.6 mmol) was added dropwise.  
The reaction mixture was then stirred at room temperature for 20 minutes after 
which ether was added until the mixture was homogeneous.  The reaction mixture 
was then washed with brine (20 mL) and the red aqueous layer extracted with ether 
until  it became  yellow.    The  organic  layer  was  then  dried  over  MgSO4  and the 
solvent removed in vacuo.  The residue was then purified on a column of silica gel 
(25 g) with a Pet Ether-EtOAc mixture (1:1) to afford 144 as brown solid (50%); mp 
91-93 
oC; 
1H NMR (400 MHz, CDCl3) δH 2.81 (3H, s, 12-H), 7.66 (1H, ddd, J = 1.0 Hz, J 
= 7.1 Hz, J = 8.1 Hz), 7.81 (1H, ddd, J 1.3 = Hz, J = 6.8 Hz, J = 8.3 Hz), 7.98 (1H, d, J = 
8.3 Hz), 8.27 (1H, d, J = 8.6 Hz), 9.1 (1H, s); 
13C NMR (100 MHz, CDCl3) δC 19.2 (CH3, 
12-C), 123.2 (CH), 126.3 (CH), 126.8 (CH), 127.7 (CH), 130.4 (C), 131.1 (CH), 133.3 
(C), 149.2 (CH), 151.1 (C), 226.9 (C, 11-C). 
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(S)-(+)-1-(5-phenyl-4,5-dihydro-1,3-oxazol-2-yl)isoquinoline  (S)-(+)-148. 
Triethylamine (2.2 mL, 15.6 mmol) was added to a solution of (R)-136 (1.65 g, 5.6 P a g e  | 109 
 
mmol) in CH2Cl2 (65 mL). The reaction was then cooled to 0 ˚C and mesyl chloride 
(0.65 mL, 8.25 mmol) was added dropwise over 15 min. The reaction vessel was 
then  allowed  to  attain  room  temperature  and  stirred  overnight.  The  reaction 
mixture was washed with water (3 × 40 mL) and the organic layer was dried over 
MgSO4. Concentration in vacuo afforded a residue which was purified via column 
chromatography on silica gel (petroleum ether-ethyl acetate, 1:1) to give an oil 
which solidified on standing.  Recrystallisation from ether gave (S)-(+)-148 (1.2 g, 
78%) as a white solid: mp 78-80 °C (Et2O); [α]D +83.5 (c 0.5, CHCl3); IR (KBr) 700, 
759, 838 (aryl), 1645 (C=N), 2866, 2931 (CH/CH2), 3064 (aryl-H) cm
-1; 
1H NMR (400 
MHz, CDCl3) δH 4.19 (1H, dd, J4α-H,4β-H = 15.2 Hz, J4α-H,5-H = 8.0 Hz, 4α-H), 4.64 (1H, dd, 
J4α-H,4β-H = 15.2 Hz, J4β-H,5-H = 10.4 Hz, 4β-H), 5.75 (1H, dd, J4β-H,5-H = 10.4 Hz, J4α-H,5-H = 
8.4 Hz, 5-H), 7.27 - 7.39 (m, 5H), 7.61-7.70 (m, 2H), 7.73 (1H, d, J = 5.2 Hz), 7.83 (1H, 
d, J = 7.2 Hz), 8.61 (1H, d, J = 5.6 Hz), 9.18 (1H, d, J = 8.4 Hz); 
13C NMR (100MHz, 
CDCl3) δC 63.9 (CH2), 80.7 (CH), 123.5 (CH), 126.1 (CH), 127.2 (CH), 127.3 (CH), 127.4 
(C), 128.4 (CH), 128.6 (CH), 128.9 (CH), 130.5 (CH), 136.8 (C), 140.7 (C), 141.9 (CH), 
146.3 (C), 162.7 (C); EI MS m/z (%) 274 (M
+•, 65), 168 (70), 128 (100), 101 (15), 82 
(35), 77 (10), 47 (5); HRMS (EI) 274.1105 (C18H14N2O requires 274.1106). 
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(±)-4-Amino-3-phenyl-1-pyridin-2-yl-butan-1-ol (±)-149:  
Method A:  SnCl2.2H2O (391 mg, 1.74 mmol) and 150 (158 mg, 0.58 mmol) were 
dissolved in anhydrous EtOH and heated to reflux overnight.  The reaction mixture 
was then allowed to reach room temperature and sat. NaHCO3 was added until pH 
= 8.  The mixture was then extracted with EtOAc (3 x 20 mL), the organic phase was 
dried over MgSO4, filtered and the solvent removed.  Only starting material was 
isolated. P a g e  | 110 
 
Method B:  A solution of 150 (310 mg, 0.57 mmol) in EtOH (5 mL) was added to a 
round bottomed flask containing Pd/C (50 mg, 30%).  The flask was evacuated and 
filled with hydrogen three times.  The mixture was then stirred vigorously overnight 
at  room  temperature.    The  reaction  mixture  was  then  filtered,  the  precipitate 
washed thoroughly with EtOH and the solvent removed in vacuo.  Only starting 
material was isolated. 
Method C:  To a solution of anhydrous nickel (II) chloride (91 mg, 0.7 mmol) in 
MeOH (5 mL) at 0 
oC was added NaBH4 (133 mg, 3.5 mmol).  The mixture was 
allowed to stir for 15 min. after which 150 (190 mg, 0.7 mmol) and NaBH4 (266 mg, 
7.0mmol)  were  added.    The  reaction  mixture  was  then  allowed  to  reach  room 
temperature  and  allowed  to  stir  for  a  further  45  min.    The  mixture  was  then 
acidified with 2M HCl and extracted with ethyl acetate (3 x 20 mL).  The aqueous 
phase was then treated with ammonia solution and extracted with CH2Cl2 (3 x 20 
mL).  The CH2Cl2 phase was dried over MgSO4 and the solvent removed to give 149 
(98%) as a brown oil: 
1H NMR (400MHz, CDCl3) δH 2.12 (m, 1H), 2.62 (m, 1H), 2.87 
(m, 3H), 4.62 (m, 1H) 7.03 – 7.26 (m, 7H), 7.54 (m, 1H), 8.43 (m, 1H). 
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(±)-4-Nitro-3-phenyl-1-pyridin-2-yl-butan-1-one  (±)-150:    Diethylamine  (0.26  mL, 
2.5 mmol) and 151 (100 mg, 0.5 mmol) were dissolved in anhydrous methanol (2 
mL).  Nitromethane (0.14 mL, 2.5 mmol) was added and the mixture heated at 
reflux overnight.  The mixture was then acidified with 2M HCl and extracted with 
DCM (3 x 20 mL).  The organic phase was then dried over MgSO4 and the solvent 
removed to afford 150 as a brown oil (41%): 
1H NMR (400MHz, CDCl3) δH 3.60 (1H, 
dd, J4α,4β = 18.4 Hz, J3,4α = 7.1 Hz, 4α-H), 3.72 (dd, J4α,4β = 18.4 Hz, J3,4β = 7.1 Hz, 1H, 
4β-H), 4.18 (m, 1H), 4.61 (1H, dd, J2α,2β = 12.1 Hz, J2α,3 = 8.1 Hz, 2α-H), 4.71 (1H, d, P a g e  | 111 
 
J2α,2β = 12.1 Hz, J2β,3 = 6.6 Hz, 2β-H), 7.22 (m, 5H), 7.41 (t, J = 6.3 Hz, 1H), 7.75 (t, J = 
7.6 Hz, 1H), 7.92 (d, J = 7.8 Hz, 1H), 8.59 (1H, d, J = 4.3 Hz, 15-H). 
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3-Phenyl-1-pyridin-2-yl-propenone 151: Adapting the method of Engberts
[92] acetyl 
pyridine (2.06 g, 17.0 mmol) and benzaldehyde (1.85 g, 16.5 mmol) were mixed in 
water (100 mL) at 4 
oC, 10% aqueous NaOH (10 ml) was added and the mixture 
stored in the fridge overnight.  The mixture was then shaken and filtered and the 
resulting  solid  recrystallised  from  ethanol  to  give  3-phenyl-1-pyridin-2-yl-
propenone 151 as yellow crystals (35%):
  1H NMR (400MHz, CDCl3) δH 7.31 – 7.37 
(3H, m), 7.43 (1H, ddd, J = 7.6, 4.8, 1.3 Hz), 7.67 (2H, m), 7.81 (1H, dt, J = 7.8, 1.8 
Hz), 7.88 (1H, d, J2,3 = 16.2 Hz, 2-H), 8.13 (1H, dt, J = 1.0, 8.1 Hz), 8.24 (1H, d, J2,3 = 
16.2 Hz, 3-H), 8.64 – 8.67 (1H, m); 
13C NMR (100 MHz, CDCl3) δC 120.9 (CH), 121.8 
(CH), 122.9 (CH), 126.6 (CH), 126.9 (CH), 128.4 (CH), 130.6 (CH), 135.2 (C), 136.8 
(CH), 137.1 (CH), 144.8 (CH), 148.8 (CH), 189.5 (C=O), 200.1 (C); IR (NaCl) ν 1700 
(C=0), 1620 (C=C) cm
-1; MS EI  HRMS (EI+) 209.0841 (C14H11NO requires 209.0843) 
in agreement with the literature.
[92] 
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Organocatalytic Reactions 
 
N
H
NH Cl3Si
DIPEA, CHCl3
Catalyst 91 20 mol%
Proline 2.0 eq
OH OH
 
General  procedure  for  the  asymmetric  allylation  of  aldimine  111  with 
allyltrichlorosilane: 
Aldimine 111 (49 mg, 0.25 mmol), proline (57 mg, 0.50 mmol), DIPEA (0.11mL, 0.63 
mmol) and catalyst (S)-91 (22 mg, 0.05 mmol) were dissolved in CH2Cl2 (2 mL).  The 
solution  was  allowed  to  stir  at  room  temperature  for  20  minutes  after  which 
allyltrichlorosilane (54 μL, 0.37 mmol) was added.  The reaction mixture was left to 
stir for 24 h after which saturated aqueous NaHCO3 (3 mL) was added to quench 
the reaction. The mixture was extracted with CH2Cl2 (3 × 10 mL) and the combined 
organic  fractions  were  dried  over  MgSO4.  Concentration  in  vacuo  followed  by 
chromatography  on  a  column  of  silica  gel  with  a  Petrol  –  EtOAc  mixture  (4:1) 
afforded 112 as a slightly yellow oil; 
1H NMR (400MHz, CDCl3) δH 2.44 – 2.59 (2H, 
m), 4.28 – 4.39 (1H, m), 5.05 – 5.11 (2H, m), 5.67 – 5.77 (1H, m), 6.31 (1H, dd, J = 
8.0 Hz, J = 1.6 Hz), 6.48 – 6.51 (1H, m), 6.58 – 6.64 (2H, m), 7.10 – 7.19 (2H, m), 7.24 
– 7.87 (4H, m). 
 
 
General procedure for the asymmetric reduction of ketones and ketimines: 
Trichlorosilane  (86  μL,  0.84  mmol)  was  slowly  added  dropwise  to  a  solution  of 
catalyst (22 mg, 0.08 mmol) and the corresponding ketone (0.40 mmol) in CHCl3 (2 
mL) at –20 ˚C. The reaction mixture was stirred for 24 h at -20 ˚C, after which 
saturated aqueous NaHCO3 (1 mL) was added to quench the reaction. The mixture 
was extracted with CH2Cl2 (3 × 10 mL) and the combined organic fractions were 
dried over MgSO4. Concentration in vacuo followed by flash chromatography on 
silica gel (3 × 15 cm) with CH2Cl2 afforded sec-alcohol 30. 
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(R)-(+)-1-Phenylethanol (R)-(+)-30: Isolated as a slightly yellow oil: [α]D +45.2 (c 
0.93, CHCl3, 64% ee)
[93], gives [α]D +49.0 (c 1.0, CHCl3, 98% ee)]; 
1H NMR (400MHz, 
CDCl3) δH 1.52 (d, J = 6.4 Hz, 3H), 2.21 (bd, 1H), 4.92 (q, J = 6.4 Hz, 1H), 7.28-7.50 (m, 
5H); 
13C NMR (100 MHz, CDCl3) δC 25.2 (CH3), 70.4 (CH), 125.4 (CH), 127.5 (CH), 
128.5 (CH), 145.9 (C); Chiral GC (Supelco β-DEX
TM), carrier gas: He (flow 2 mL/min), 
injection temp: 220 ˚C; column temp: initial temp, 80 ˚C for 2 min; rate, 1.5 ˚C/min; 
final temperature 160 ˚C (tR = 23.31 min; tS = 24.21 min). 
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(+)-N-(1-(benzofuran-2-yl)ethyl)-4-methoxybenzenamine: 77% yield, purified on a 
column of silica gel with a Petrol – EtOAc mixture (95:5) to give a colourless oil, 
Chiral HPLC (Chiracel OJ-H) Hexane:
iPrOH 80:20 0.75 mL min
-1 (tmajor = 21.27 min, 
tminor = 24.56 min) showed 75% ee; [α]D +181 (c = 0.2, CHCl3); 
1H NMR (400 MHz, 
CDCl3) δH 1.56 (3H, d, J11-H,10-H = 6.8 Hz, 11-H), 3.65 (3H, s, 16-H), 4.58 (1H, q, J11-H,10-H 
= 6.8 Hz, 10-H), 6.45 (1H, s, 3-H), 6.55 (2H, m, 14-H), 6.67 (2H, m, 13-H), 7.12 (2H, 
m), 7.40 (2H, m); EI MS m/z (%) 267 (M
+, 65), 145 (100), 123 (44), 115 (42); HRMS 
(EI) 267.1259 (C17H17N2O requires 267.1261). 
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(+)-4-methoxy-N-(1-(thiophen-2-yl)ethyl)benzenamine:    77%,  yield  purified  on  a 
column of silica gel with a Petrol – EtOAc mixture (95:5) to give a yellow oil, Chiral 
HPLC (Chiracel OJ-H) Hexane:
iPrOH 80:20 0.75 mL min
-1 (tmajor = 24.25 min, tminor = 
26.89 min) showed 60% ee; [α]D +5.5 (c = 1.0, CHCl3); 
1H NMR (400 MHz, CDCl3) δH 
1.52 (3H, d, J7-H,6-H = 6.8 Hz, 7-H), 3.65 (3H, s, 12-H), 4.66 (1H, q, J7-H,6-H = 6.8 Hz, 6-H) 
6.52 (2H, m, 8-H), 6.67 (2H, m, 9-H), 6.88 (2H, m, 3-H, 4-H), 7.17 (1H, m, 5-H);  
13C 
NMR (CDCl3, 100 MHz) δC 20.5 (CH3, 7-C), 50.6 (CH, 6-C), 55.7 (CH3, 12-C), 114.8 
(CH), 115.2 (CH), 122.9 (CH), 123.7 (CH), 128.7 (CH), 141.0 (C, 8-C), 150.5 (C, 2-C), 
152.5 (C, 11-C); EI MS m/z (%)  233 (M
+, 39), 216 (54), 123 (37), 111 (92), 83 (100); 
HRMS (EI) 233.0874 (C13H15NOS requires 233.0873). 
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(-)-4-methoxy-N-(1-(pyridin-4-yl)ethyl)benzenamine:    70%  yield,  purified  on  a 
column of silica gel with a Petrol – EtOAc mixture (7:3) to give an off-white solid, 
Chiral HPLC (Chiracel OJ-H) Hexane:
iPrOH 80:20 0.75 mL min
-1 (tminor = 27.89 min, 
tmajor = 38.29 min) showed 82% ee; [α]D -19.0 (c = 1.0, CH2Cl2); 
1H NMR (400 MHz, 
CDCl3) δH 1.43 (3H, d, J6-H,5-H = 6.8 Hz, 6-H), 3.63 (3H, s, 11-H), 4.31 (1H, q, J6-H,5-H = 
6.8 Hz, 5-H), 6.33 (2H, d, J8-H, 9-H = 3.6 Hz,  9-H), 6.61 (2H, d, J8-H, 9-H = 3.6 Hz,  8-H), 
7.22 (2H, d, J2-H, 3-H = 2.4 Hz, 3-H), 8.46 (2H, d, J2-H, 3-H = 2.8 Hz, 2-H); 
13C NMR (CDCl3, 
100 MHz) δC 24.6 (CH3, 6-C), 53.5 (CH, 5-H), 55.7 (CH3, 11-H), 114.5 (CH), 114.8 (CH), 
121.3 (CH), 140.8 (C, 7-C), 149.9 (CH), 152.3 (C, 10-C), 154.9 (C, 4-C); CI MS m/z (%) P a g e  | 115 
 
229 (M
+, 100), 213 (8), 123 (15), 108 (12), 71 (15); HRMS (CI) 229.1341 (C14H17N2O 
requires 229.1342). 
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(-)-4-methoxy-N-(1-(pyridin-2-yl)ethyl)benzenamine: purified on a column of silica 
gel  with  a  Petrol  –  EtOAc  mixture  (7:3)  to  give  an  off-white  solid,  Chiral  HPLC 
(Chiracel OJ-H) Hexane:
iPrOH 80:20 0.75 mL min
-1 (tminor = 27.89 min, tmajor = 38.29 
min) showed 79% ee; [α]D -15.0 (c = 0.1, CHCl3); 
1H NMR (400 MHz, CDCl3) δH 1.45 
(3H, d, J8-H,7-H = 6.8 Hz, 8-H), 3.62 (3H, s, 13-H), 4.47 (1H, q, J8-H,7-H = 6.8 Hz, 7-H), 
6.45 (2H, d, J , 10-H), 6.62 (2H, d, 11-H), 7.06 (1H, dd, J = 7.2 Hz, J = 5.2 Hz, 5-H), 
7.27 (1H, d, J = 8.0 Hz, 3-H), 7.53 (1H, dt, J = 1.6 Hz, J = 7.6 Hz, 4-H), 8.50 (d, J = 4.98 
Hz, 6-H); EI MS m/z (%) 228 (M
+, 100), 213 (98), 169 (37), 150 (97), 122 (90), 106 
(97);  HRMS  (EI)  228.1263  (C14H16N2O  requires  228.1265)  in  agreement  with 
literature values.
[94]  
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N-(1-(furan-2-yl)ethyl)-4-methoxybenzenamine: 70% yield, purified on a column of 
silica  gel  with  a  Petrol  –  EtOAc  mixture  94:6,  ,  Chiral  HPLC  (Chiracel  OJ-H) 
Hexane:
iPrOH 80:20 0.75 mL min
-1 (tminor = 41.51 min, tmajor = 49.19 min) showed 
55% ee; 
1H NMR (400 MHz, CDCl3) δH 1.46 (3H, d, J7-H,6-H = 6.8 Hz, 7-H), 3.66 (3H, s, 
12-H), 4.47 (1H, q, J7-H,6-H = 6.8 Hz, 6-H), 6.06 (1H, d, J3-H, 4-H = 2.4 Hz, 3-H), 6.21 (1H, 
d, J3-H, 4-H = 2.4 Hz, 4-H), 6.52 (2H, d, J9-H, 10-H = 3.6 Hz, 9-H), 6.67 (2H, d, J9-H, 10-H = 3.6 P a g e  | 116 
 
Hz, 10-H), 7.24 (1H, s, 5-H); 
13C NMR (CDCl3, 100 MHz) δC 20.9 (CH3, 7-C), 48.5 (CH, 
6-C), 55.7 (CH3, 12-C), 105.1 (CH, 3-C), 110.1 (CH, 4-C), 114.8 (CH, 9-C), 115.3 (CH, 
10-C), 141.0 (C, 8-C), 152.5 (C, 11-C), 157.4 (C, 2-C); EI MS m/z (%) 217 (M
+, 55), 202 
(37),  123  (42),  95  (100);  HRMS  (EI)  217.1103  (C13H15N2O  requires  217.1101)  in 
agreement with literature values.
[95] 
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4-methoxy-N-(1-phenylethyl)benzenamine: Isolated as a slightly yellow oil, Chiral 
HPLC (Chiracel OJ-H) Hexane:
iPrOH 99:1 0.75 mL min
-1 (tmajor = 13.12 min, tminor = 
14.36 min) showed 79% ee; 
1H NMR (400 MHz, CDCl3) δH 0.87 (3H, t, J7-H,6-H = 7.8 Hz, 
7-H), 1.73 (2H, m, 6-H), 3.56 (3H, s, 12-H), 4.08 (1H, t, J6-H,5-H = 6.8 Hz, 5-H), 6.40 (2H, 
d, 9-H), 6.59 (2H, d, 10-H), 7.22 (5H, m, 1-H, 2-H, 3-H); 
13C NMR (CDCl3, 100 MHz) δC 
10.9 (CH3, 7-C), 31.7 (CH2, 6-C), 55.8 (CH, 5-C), 60.6 (CH3, 12-C), 114.5 (CH), 114.8 
(CH), 126.6 (CH), 126.9 (CH), 128.5 (CH), 141.9 (C, 8-C), 144.2 (C, 4-C), 151.9 (C, 11-
C); EI MS m/z (%) 241 (M
+, 57), 212 (100), 91 (67); HRMS (EI) 241.1467 (C16H19ON 
requires 241.1469) in agreement with literature.
[96] 
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(+)-4-methoxy-N-(1-(5-(trimethylsilyl)furan-2-yl)ethyl)benzenamine:  Isolated  as  a 
colourless oil, [α]D +13.4 (c = 1.0, CHCl3); 
1H NMR (400 MHz, CDCl3) δH 0.05 (9H, s, 
13-H), 1.35 (3H, d, J7-H,6-H = 6.8 Hz, 7-H), 3.55 (3H, s, 12-H), 4.38 (1H, q, J7-H,6-H = 6.8 
Hz, 6-H), 5.96 (1H, d, J3-H,4-H = 4.6 Hz, 3-H), 6.31 (1H, d, J3-H,4-H = 4.8 Hz, 4-H), 6.43 P a g e  | 117 
 
(2H, d, 9-H), 6.57 (2H, d, 10-H); 
13C NMR (CDCl3, 100 MHz) δC 0.00 (CH3, 13-C), 22.5 
(CH3, 7-C), 50.2 (CH, 6-C), 57.3 (CH3, 12-C), 106.5 (CH, 3-C), 116.3 (CH, 4-C), 116.8 
(CH, 9-C), 121.7 (CH, 10-C), 142.9 (C, 8-C), 153.9 (C, 11-C), 160.7 (C, 2-C), 163.5 (C, 5-
C); EI MS m/z (%) 289 (M
+, 20), 167 (70), 123 (15), 83 (99), 75 (30), 49 (100); HRMS 
(EI) 289.1498 (C16H23NO2Si requires 289.1495). 
 
O
OH
1
2
3 4
5
6
7
8 9
 
1-(2,5-dimethylfuran-3-yl)ethanol: Isolated as a colourless oil, 
1H NMR (400MHz, 
CDCl3) δH 1.35 (3H, d, J = 6.3 Hz, 7-H), 2.16 (3H, s, 8-H), 2.17 (3H, s, 9-H), 4.71 (1H, q, 
J = 6.3 Hz), 5.93 (1H, s, 4-H); Chiral GC (Supelco β-DEX
TM), carrier gas: He (flow 2 
mL/min), injection temp: 220 ˚C; column temp: initial temp, 80 ˚C for 7 min; rate, 
3.0 ˚C/min; final temperature 200 ˚C (t1 = 29.90 min; t2 = 30.08 min). 
 
 
O
OH
1
2
3 4
5 6 7
8
 
1-(5-methylfuran-2-yl)ethanol: 
1H NMR (400MHz, CDCl3) δH 1.55 (3H, d, J7-H,8-H = 6.6 
Hz, 8-H), 2.31 (3H, s, 6-H), 4.85 (1H, dq, J = 1.5 Hz, J7-h,8-H = 6.6 Hz, 7-H), 5.93 (1H, dq, 
J3-H,4-H = 3.0 Hz, J = 1.0 Hz), 6.13 (1H, d, J = 3.0 Hz); Chiral GC (Supelco β-DEX
TM), 
carrier gas: He (flow 2 mL/min), injection temp: 220 ˚C; column temp: initial temp, 
80 ˚C for 5 min; rate, 2.0 ˚C/min; final temperature 200 ˚C (t1 = 12.32 min; t2 = 12.65 
min). 
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